Note that the content is AI-generated and might contain mistakes. Generation might take some time.
If AI keeps you waiting, feel free to play the mini-game below in the meantime!
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:us-gaap="http://fasb.org/us-gaap/2025" xmlns:us-roles="http://fasb.org/us-roles/2025" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2024-01-31" xmlns:country="http://xbrl.sec.gov/country/2025" xmlns:srt="http://fasb.org/srt/2025" xmlns:DYCQ="http://dtcloud.com/20250930">
<head>
<title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02E_US%2DGAAP%2D2025 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_DYCQ_dtcloud.com_20250930 -->
<!-- Field: Set; Name: xdx; ID: xdx_042_20250101_20250930 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DDocumentFiscalPeriodFocus_Q3 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001944212 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_072_SO_form10%2Dq.xdxs -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000004" name="dei:DocumentFiscalPeriodFocus">Q3</ix:nonNumeric>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000005" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000006" name="dei:EntityCentralIndexKey">0001944212</ix:nonNumeric>
<ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2025-09-30" id="xdx2ixbrl0054" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0082" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0085" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2025-09-30" id="xdx2ixbrl0096" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:CommitmentsAndContingencies" contextRef="AsOf2024-12-31" id="xdx2ixbrl0097" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2024-07-012024-09-30" id="xdx2ixbrl0155" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0157" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2025-07-012025-09-30" id="xdx2ixbrl0174" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0254" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0260" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0261" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0265" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0266" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0270" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0271" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0276" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0282" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0283" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0287" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0288" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-04-012025-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0292" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0293" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0298" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0304" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-07-012025-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0305" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0309" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-07-012025-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0310" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0319" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0320" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0325" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0340" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0347" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValueRepresentativeShare" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0354" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValueRepresentativeShare" contextRef="From2024-01-012024-03-31" id="xdx2ixbrl0355" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0361" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0366" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="xdx2ixbrl0368" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfAccretionOfCarryingValueToRedemptionValue" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0371" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0376" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0377" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="xdx2ixbrl0381" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0382" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0387" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0393" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0394" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_CommonStockMember" id="xdx2ixbrl0398" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0399" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0404" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0411" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0417" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0418" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0422" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0423" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_CommonStockMember" id="xdx2ixbrl0427" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0428" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0433" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember" id="xdx2ixbrl0440" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0459" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherDeposits" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0479" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionPaymentsDepositedInTrustAccount" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0483" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0486" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0495" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:ProceedsFromOtherDebt" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0501" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0504" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0506" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0509" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2025-09-30" id="xdx2ixbrl0521" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:IssuanceOfRepresentativeShare" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0527" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0530" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0533" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:AccretionOfCarryingValueToRedemptionValue" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0536" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToOrdinarySharesSubjectToRedemption" contextRef="From2024-01-012024-09-30" id="xdx2ixbrl0540" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="DYCQ:AccruedUnderwritingCompensation" contextRef="From2025-01-01to2025-09-30" id="xdx2ixbrl0545" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2025-09-30" id="xdx2ixbrl0674" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2024-12-31" id="xdx2ixbrl0856" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2025-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0891" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2025-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0892" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0901" unitRef="USD" xs:nil="true"></ix:nonFraction>
<ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember" id="xdx2ixbrl0902" unitRef="USD" xs:nil="true"></ix:nonFraction>
</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="dycq-20250930.xsd" xlink:type="simple"/>
</ix:references>
<ix:resources>
<xbrli:context id="From2025-01-01to2025-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_UnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:UnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_OrdinarySharesMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:OrdinarySharesMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_us-gaap_RightsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:RightsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-10-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-10-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_RelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_RelatedPartyMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:OrdinarySharesSubjectToPossibleRedemptionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2023-12-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2023-12-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2023-12-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2023-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-03-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-03-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-03-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-03-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-03-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-06-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-06-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-06-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-06-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-06-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-03-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-03-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-03-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-04-012025-06-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-01</xbrli:startDate>
<xbrli:endDate>2025-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-04-012025-06-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-01</xbrli:startDate>
<xbrli:endDate>2025-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-01</xbrli:startDate>
<xbrli:endDate>2025-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-04-012025-06-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-01</xbrli:startDate>
<xbrli:endDate>2025-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-03-31_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-03-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-03-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-04-012024-06-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-04-01</xbrli:startDate>
<xbrli:endDate>2024-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-04-012024-06-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-04-01</xbrli:startDate>
<xbrli:endDate>2024-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-04-01</xbrli:startDate>
<xbrli:endDate>2024-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-04-012024-06-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-04-01</xbrli:startDate>
<xbrli:endDate>2024-06-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-09-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-09-30_us-gaap_AdditionalPaidInCapitalMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-09-30_us-gaap_RetainedEarningsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-09-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-02-232024-02-23_us-gaap_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-02-23</xbrli:startDate>
<xbrli:endDate>2024-02-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-02-232024-02-23_custom_PublicUnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">DYCQ:PublicUnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-02-23</xbrli:startDate>
<xbrli:endDate>2024-02-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-02-23_us-gaap_IPOMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-02-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-02-232024-02-23_custom_PrivatePlacementUnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">DYCQ:PrivatePlacementUnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-02-23</xbrli:startDate>
<xbrli:endDate>2024-02-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-02-23_custom_PrivatePlacementUnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">DYCQ:PrivatePlacementUnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-02-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-02-23_custom_PublicUnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">DYCQ:PublicUnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-02-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_srt_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_custom_PostBusinessCombinationMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">DYCQ:PostBusinessCombinationMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_srt_MinimumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_custom_PublicUnitsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">DYCQ:PublicUnitsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_custom_EachMonthlyExtensionMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:StatementScenarioAxis">DYCQ:EachMonthlyExtensionMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-202025-01-20_us-gaap_InvestorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-20</xbrli:startDate>
<xbrli:endDate>2025-01-20</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-01-20_us-gaap_InvestorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-01-20</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-01-20_us-gaap_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-01-20</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-02-22">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-02-22</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-03-242025-03-24">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-03-24</xbrli:startDate>
<xbrli:endDate>2025-03-24</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-24">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-24</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-03-25">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-03-25</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-04-232025-04-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-04-23</xbrli:startDate>
<xbrli:endDate>2025-04-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-04-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-04-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-05-212025-05-21_custom_VotingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">DYCQ:VotingAgreementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-05-21</xbrli:startDate>
<xbrli:endDate>2025-05-21</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-05-232025-05-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-05-23</xbrli:startDate>
<xbrli:endDate>2025-05-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-05-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-05-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-07-30">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-07-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-09-232025-09-23">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-09-23</xbrli:startDate>
<xbrli:endDate>2025-09-23</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-09-292025-09-29_us-gaap_InvestorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-09-29</xbrli:startDate>
<xbrli:endDate>2025-09-29</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-29_us-gaap_InvestorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:InvestorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-29</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-29_us-gaap_PrivatePlacementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-29</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-09-03">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-09-03</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:RedeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:NonredeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:RedeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:NonredeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:RedeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:NonredeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-07-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:RedeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">DYCQ:NonredeemableOrdinaryStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-07-01</xbrli:startDate>
<xbrli:endDate>2024-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_us-gaap_PrivatePlacementMember_custom_SponsorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">DYCQ:SponsorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_PrivatePlacementMember_custom_SponsorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">DYCQ:SponsorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2022-07-072022-07-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2022-07-07</xbrli:startDate>
<xbrli:endDate>2022-07-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2024-01-012024-12-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2024-01-01</xbrli:startDate>
<xbrli:endDate>2024-12-31</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_SponsorMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">DYCQ:SponsorMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_srt_MaximumMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_custom_WorkingCapitalLoansMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">DYCQ:WorkingCapitalLoansMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_VotingAgreementsMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">DYCQ:VotingAgreementsMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-05-27">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-05-27</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-18">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-18</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-06-25">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-06-25</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-07-31">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-07-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-24">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-24</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_us-gaap_CommonStockMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-09-30_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-09-30</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel2Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_FairValueMeasurementsRecurringMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-12-31</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="From2025-01-012025-09-30_custom_UnderwriterAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">DYCQ:UnderwriterAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2025-01-01</xbrli:startDate>
<xbrli:endDate>2025-09-30</xbrli:endDate>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2024-02-23_custom_BrooklineCapitalMarketsMember_custom_UnderwriterAgreementMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="dei:LegalEntityAxis">DYCQ:BrooklineCapitalMarketsMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">DYCQ:UnderwriterAgreementMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2024-02-23</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:context id="AsOf2025-11-19_us-gaap_SubsequentEventMember_custom_UnsecuredPromisssoryNoteMember">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0001944212</xbrli:identifier>
<xbrli:segment>
<xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
<xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">DYCQ:UnsecuredPromisssoryNoteMember</xbrldi:explicitMember>
</xbrli:segment>
</xbrli:entity>
<xbrli:period>
<xbrli:instant>2025-11-19</xbrli:instant>
</xbrli:period>
</xbrli:context>
<xbrli:unit id="USD">
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="Shares">
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unit>
<xbrli:unit id="USDPShares">
<xbrli:divide>
<xbrli:unitNumerator>
<xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unitNumerator>
<xbrli:unitDenominator>
<xbrli:measure>xbrli:shares</xbrli:measure>
</xbrli:unitDenominator>
</xbrli:divide>
</xbrli:unit>
<xbrli:unit id="Pure">
<xbrli:measure>xbrli:pure</xbrli:measure>
</xbrli:unit>
</ix:resources>
</ix:header>
</div>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; font-size: 1pt; border-bottom: Black 1pt solid"> </div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>FORM
<span id="xdx_903_edei--DocumentType_c20250101__20250930_z9mk8igAmbRd"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000013" name="dei:DocumentType">10-Q</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Mark
One)</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--DocumentQuarterlyReport_c20250101__20250930_zQ6es5v1Uyw4"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleantrue" id="Fact000014" name="dei:DocumentQuarterlyReport">☒</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>QUARTERLY
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the quarterly period ended <span id="xdx_907_edei--DocumentPeriodEndDate_c20250101__20250930_z42SUBfVflCg"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:datemonthdayyearen" id="Fact000015" name="dei:DocumentPeriodEndDate">September 30, <span id="xdx_901_edei--DocumentFiscalYearFocus_c20250101__20250930_zDuy5rfTIHOi" title="Document Fiscal Year Focus"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000017" name="dei:DocumentFiscalYearFocus">2025</ix:nonNumeric></span></ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--DocumentTransitionReport_c20250101__20250930_zt6mhvBchlVj"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleanfalse" id="Fact000018" name="dei:DocumentTransitionReport">☐</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TRANSITION
REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 </b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>For
the transition period from _______ to </b>______</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Commission
File Number <span id="xdx_905_edei--EntityFileNumber_c20250101__20250930_zw2P1BMOev3e"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000019" name="dei:EntityFileNumber">001-41967</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span style="text-decoration: underline"><span id="xdx_902_edei--EntityRegistrantName_c20250101__20250930_zIX25IJG0qt1"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000020" name="dei:EntityRegistrantName">DT
Cloud Acquisition Corporation</ix:nonNumeric></span></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Exact
name of registrant as specified in its charter)</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityIncorporationStateCountryCode_c20250101__20250930_zKL4fnNCeiv2"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt-sec:edgarprovcountryen" id="Fact000021" name="dei:EntityIncorporationStateCountryCode">Cayman Islands</ix:nonNumeric></span></b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 49%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>n/a
<span id="xdx_90B_edei--EntityTaxIdentificationNumber_c20250101__20250930_zab0xua9rghi" style="display: none"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000022" name="dei:EntityTaxIdentificationNumber">00-0000000</ix:nonNumeric></span> </b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(State
or other jurisdiction of</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>incorporation
or organization)</b></span></p></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(I.R.S.
Employer</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Identification
No.)</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_907_edei--EntityAddressAddressLine1_c20250101__20250930_zvQsGkUegF5a"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000023" name="dei:EntityAddressAddressLine1">30
Orange Street</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="xdx_90B_edei--EntityAddressCityOrTown_c20250101__20250930_zo4MrahvNyUk" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000024" name="dei:EntityAddressCityOrTown">London</ix:nonNumeric></b></span><b><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">,
<span id="xdx_90B_edei--EntityAddressCountry_c20250101__20250930_zPM2FPcj4Yrc"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt-sec:countrynameen" id="Fact000025" name="dei:EntityAddressCountry">United Kingdom</ix:nonNumeric></span></span></b></p></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_901_edei--EntityAddressPostalZipCode_c20250101__20250930_zmwcckXCqssl"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000026" name="dei:EntityAddressPostalZipCode">WC2H
7HF</ix:nonNumeric></span></b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Address
of principal executive offices)</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Zip
Code)</b></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_906_edei--CityAreaCode_c20250101__20250930_zk0U2qYFYbzg"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000027" name="dei:CityAreaCode">+44</ix:nonNumeric></span>
<span id="xdx_906_edei--LocalPhoneNumber_c20250101__20250930_z88uiXxDHE3b"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000028" name="dei:LocalPhoneNumber">7918725316</ix:nonNumeric></span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Registrant’s
telephone number, including area code</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>N/A</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Former
name or former address, if changed since last report)</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
registered pursuant to Section 12(b) of the Act:</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 40%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title
of each class</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Trading
Symbol(s)</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name
of each exchange on which registered</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--Security12bTitle_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zkwBrBXaaztd"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_UnitsMember" id="Fact000029" name="dei:Security12bTitle">Units</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--TradingSymbol_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zBqW8E1t12kb"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_UnitsMember" id="Fact000030" name="dei:TradingSymbol">DYCQU</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--SecurityExchangeName_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--UnitsMember_zDi5G3sLWxll"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_UnitsMember" format="ixt-sec:exchnameen" id="Fact000031" name="dei:SecurityExchangeName">The
Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_909_edei--Security12bTitle_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zYyAYPM5B52a"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_OrdinarySharesMember" id="Fact000032" name="dei:Security12bTitle">Ordinary
Shares</ix:nonNumeric></span> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_edei--TradingSymbol_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_zArJs4VYMkT8"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_OrdinarySharesMember" id="Fact000033" name="dei:TradingSymbol">DYCQ</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_907_edei--SecurityExchangeName_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesMember_z1mcW9BZEHB7"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_OrdinarySharesMember" format="ixt-sec:exchnameen" id="Fact000034" name="dei:SecurityExchangeName">The
Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--Security12bTitle_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RightsMember_z4pzuPqOlAh9"><ix:nonNumeric contextRef="From2025-01-012025-09-30_us-gaap_RightsMember" id="Fact000035" name="dei:Security12bTitle">Rights</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_edei--TradingSymbol_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RightsMember_zwPJWg8kL7Wj"><ix:nonNumeric contextRef="From2025-01-012025-09-30_us-gaap_RightsMember" id="Fact000036" name="dei:TradingSymbol">DYCQR</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--SecurityExchangeName_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RightsMember_zdr12gTXq2ng"><ix:nonNumeric contextRef="From2025-01-012025-09-30_us-gaap_RightsMember" format="ixt-sec:exchnameen" id="Fact000037" name="dei:SecurityExchangeName">The
Nasdaq Stock Market LLC</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange
Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days. <span id="xdx_905_edei--EntityCurrentReportingStatus_c20250101__20250930_zCk6kTMktVIa"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000038" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric></span> ☒ No ☐</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule
405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant
was required to submit such files). <span id="xdx_908_edei--EntityInteractiveDataCurrent_c20250101__20250930_zZuNZZqdE1zj"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000039" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric></span> ☒ No ☐</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large
accelerated filer</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☐</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated
filer</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 10%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☐</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_edei--EntityFilerCategory_c20250101__20250930_zpf0LKXBbvn6"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt-sec:entityfilercategoryen" id="Fact000040" name="dei:EntityFilerCategory">Non-accelerated
filer</ix:nonNumeric></span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">☒</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller
reporting company</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_908_edei--EntitySmallBusiness_c20250101__20250930_zXPwT96naOV"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleantrue" id="Fact000041" name="dei:EntitySmallBusiness">☒</ix:nonNumeric></span></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging
growth company</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--EntityEmergingGrowthCompany_c20250101__20250930_zS6zz4w0Qii8"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleantrue" id="Fact000042" name="dei:EntityEmergingGrowthCompany">☒</ix:nonNumeric></span></span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span id="xdx_90C_edei--EntityExTransitionPeriod_c20250101__20250930_zCy7nPfkEypf"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleanfalse" id="Fact000043" name="dei:EntityExTransitionPeriod">☐</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes <span id="xdx_902_edei--EntityShellCompany_dbT_c20250101__20250930_z5wifptaE9Ef"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" format="ixt:booleantrue" id="Fact000044" name="dei:EntityShellCompany">☒</ix:nonNumeric></span> No ☐</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of October 30, 2025, there were <span id="xdx_90B_edei--EntityCommonStockSharesOutstanding_iI_c20251030_z5ss9HmrMKcd"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2025-10-30" id="Fact000045" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,206,382</ix:nonFraction></span>
ordinary shares, par value $<span id="xdx_90F_edei--EntityListingParValuePerShare_c20250101__20250930_z9wp3RgywXp1"><ix:nonFraction name="dei:EntityListingParValuePerShare" contextRef="From2025-01-01to2025-09-30" id="Fact000046" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>
per share, issued and outstanding.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 4pt solid"> </div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 1 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%"> </td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
Cloud Acquisition Corporation</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-001">Part I. Financial Information</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-002">Item 1. Financial Statements</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-1</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-001">Unaudited Balance Sheets as of September 30, 2025 and December 31, 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-002">Unaudited Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-003">Unaudited Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-004">Unaudited Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-005">Notes to Unaudited Financial Statements</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6
</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-003">Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-004">Item 3. Quantitative and Qualitative Disclosures About Market Risk</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-005">Item 4. Controls and Procedures</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">9</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-006">Part II. Other Information</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-007">Item 1. Legal Proceedings</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-008">Item 1A. Risk Factors</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-009">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-010">Item 3. Defaults Upon Senior Securities</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-011">Item 4. Mine Safety Disclosures</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-012">Item 5. Other Information</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-013">Item 6. Exhibits</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#Y-014">Part III. Signatures</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-001"></span>PART
I FINANCIAL INFORMATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-002"></span>ITEM
1. FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>INDEX
TO FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-001">Unaudited Balance Sheets as of September 30, 2025 and December 31, 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-2</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-002">Unaudited Statements of Operations for the Three and Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-3</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-003">Unaudited Statements of Changes in Shareholders’ Deficit for the Three and Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-4</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-004">Unaudited Statements of Cash Flows for the Nine Months Ended September 30, 2025 and 2024</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-5</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#F-005">Notes to Unaudited Financial Statements</a></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">F-6
to F-20</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 3; Options: NewSection -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F-001"></span>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
BALANCE SHEETS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_306_111_z0TfCmDyDhG3" summary="xdx: Statement - Balance Sheets (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_49C_20250930_zZPwqgH5O6xc" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of <br/>
September 30, 2025</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_49D_20241231_zlE7hiNJtku" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">As of <br/>
December 31, 2024</p></td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: justify"> </td><td> </td>
<td colspan="2" style="text-align: center"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: center"> </td><td> </td></tr>
<tr id="xdx_405_eus-gaap--AssetsAbstract_iB_z3HH3RBmycSh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold">ASSETS</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--AssetsCurrentAbstract_i01B_zqNiBLQInJVk" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Current Assets:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_403_eus-gaap--Cash_i02I_maCztON_z2cOG7iKbfv5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 10pt; width: 62%">Cash</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0054">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-12-31" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,021</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr>
<tr id="xdx_409_eus-gaap--PrepaidExpenseCurrent_i02I_maCztON_zN39Q5S5gib3" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Prepaid expenses</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2025-09-30" id="Fact000057" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,871</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:PrepaidExpenseCurrent" contextRef="AsOf2024-12-31" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">16,830</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_402_eus-gaap--AssetsCurrent_i02TI_mtCztON_maCzlJE_z1Jjkc1qwpB5" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Total Current Assets</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2025-09-30" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22,871</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsCurrent" contextRef="AsOf2024-12-31" id="Fact000061" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,851</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--AssetsHeldInTrustNoncurrent_i01I_maCzlJE_zriPV9dP6809" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Cash and Investments held in trust account</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2025-09-30" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,598,106</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2024-12-31" id="Fact000064" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,345,071</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_401_eus-gaap--Assets_i01TI_mtCzlJE_zVk3VBDiwklk" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL ASSETS</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2025-09-30" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,620,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:Assets" contextRef="AsOf2024-12-31" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,513,922</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--LiabilitiesAndStockholdersEquityAbstract_iB_zE4ZWzK0Ffhd" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">LIABILITIES AND SHAREHOLDERS’ DEFICIT</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_401_eus-gaap--LiabilitiesCurrentAbstract_i01B_zfx2zIQ0V3L4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Current Liabilities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40F_eus-gaap--AccruedLiabilitiesCurrent_i02I_maCzwNf_zS6G9hqBjfEc" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left">Accrued liabilities</td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2025-09-30" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">141,681</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:AccruedLiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000076" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,060</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40A_eus-gaap--OtherLiabilitiesCurrent_i02I_hus-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--RelatedPartyMember_maCzwNf_zulfqZdxiUL8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 10pt; text-align: left">Due to related party</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2025-09-30_us-gaap_RelatedPartyMember" id="Fact000078" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,798</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:OtherLiabilitiesCurrent" contextRef="AsOf2024-12-31_us-gaap_RelatedPartyMember" id="Fact000079" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,759</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--SecuredDebtCurrent_i02I_maCzwNf_zRXYRZ66Ndv2" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left">Promissory note</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2025-09-30" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">715,325</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0082">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40A_eus-gaap--OtherNotesPayableCurrent_i02I_maCzwNf_zeTKhy4G8Ei6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Other payable</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2025-09-30" id="Fact000084" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0085">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_408_eus-gaap--LiabilitiesCurrent_i02TI_mtCzwNf_maCzIFx_z29PX1Mw2Bcc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Total Current Liabilities</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2025-09-30" id="Fact000087" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,556,804</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesCurrent" contextRef="AsOf2024-12-31" id="Fact000088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">297,819</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_409_eus-gaap--DeferredCompensationLiabilityClassifiedNoncurrent_i01I_maCzIFx_zlYId09Sdv2h" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Deferred Underwriting Compensation</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" contextRef="AsOf2025-09-30" id="Fact000090" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:DeferredCompensationLiabilityClassifiedNoncurrent" contextRef="AsOf2024-12-31" id="Fact000091" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--Liabilities_i01TI_mtCzIFx_maLASEzruk_z3JUksC66Wh3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left; padding-bottom: 1pt">TOTAL LIABILITIES</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2025-09-30" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,281,804</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:Liabilities" contextRef="AsOf2024-12-31" id="Fact000094" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,022,819</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_401_eus-gaap--CommitmentsAndContingencies_i01I_maLASEzruk_zgMeTGbhEwo8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Commitments and contingencies</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0096">-</span></span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0097">-</span></span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--TemporaryEquityCarryingAmountAttributableToParent_i01I_maLASEzruk_z8RXIfdRar8f" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Ordinary shares subject to possible redemption, <span id="xdx_90B_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20250930_zJLUdkoeUtc1" title="Temporary equity, shares issued"><span id="xdx_904_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20250930_zQlVsAp6z3cc" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2025-09-30" id="Fact000102" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2025-09-30" id="Fact000104" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">143,382</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90C_eus-gaap--TemporaryEquitySharesIssued_iI_pid_c20241231_zIfWxu2eIUVa" title="Temporary equity, shares issued"><span id="xdx_906_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20241231_zsxBiIy1lyqf" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesIssued" contextRef="AsOf2024-12-31" id="Fact000106" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000108" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding at redemption value of $<span id="xdx_90C_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pid_c20250930_zrmTy5QX6aug" title="Temporary equity, redemption price per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2025-09-30" id="Fact000110" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.15</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--TemporaryEquityRedemptionPricePerShare_iI_pid_c20241231_zFeK6JqhA4pb" title="Temporary equity, redemption price per share"><ix:nonFraction name="us-gaap:TemporaryEquityRedemptionPricePerShare" contextRef="AsOf2024-12-31" id="Fact000112" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.48</ix:nonFraction></span> as of September 30, 2025 and December 31, 2024, respectively</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2025-09-30" id="Fact000099" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,598,106</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" contextRef="AsOf2024-12-31" id="Fact000100" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,345,071</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_409_eus-gaap--StockholdersEquityAbstract_i01B_z8ue37vfotk7" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Shareholders’ Deficit:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_406_eus-gaap--CommonStockValue_i02I_maCzvPr_maSEz7eW_zJhpM6y1XDE5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Ordinary shares, $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250930_z7dFpzP4l1Zb" title="Ordinary shares, par value"><span id="xdx_909_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20241231_ziPgclTZWji9" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-09-30" id="Fact000120" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-12-31" id="Fact000122" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></ix:nonFraction></span></span> par value; <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250930_z7nXVg1n2Le7" title="Ordinary shares, shares authorized"><span id="xdx_90D_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20241231_zBnZ4W37GSH8" title="Ordinary shares, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-09-30" id="Fact000124" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2024-12-31" id="Fact000126" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></ix:nonFraction></span></span> shares authorized; <span id="xdx_903_eus-gaap--CommonStockSharesIssued_iI_c20250930_zgnaFOiG9pp4" title="Ordinary shares, shares issued"><span id="xdx_90F_eus-gaap--CommonStockSharesOutstanding_iI_c20250930_zZADTB9U5gq8" title="Ordinary shares, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-09-30" id="Fact000128" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-09-30" id="Fact000130" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_c20241231_zKmIiA68TSQg" title="Ordinary shares, shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20241231_zQAaR2K96uoc" title="Ordinary shares, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31" id="Fact000132" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000134" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span> shares issued and outstanding (excluding <span id="xdx_903_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_pid_c20250930_zhhebSCHm0sg" title="Subject to possible redemption, number of shares"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2025-09-30" id="Fact000136" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">143,382</ix:nonFraction></span> and <span id="xdx_908_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_pid_c20241231_zyErA5UJSbe8" title="Subject to possible redemption, number of shares"><ix:nonFraction name="us-gaap:SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares" contextRef="AsOf2024-12-31" id="Fact000138" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> shares, subject to possible redemption as of September 30, 2025 and December 31, 2024, respectively)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2025-09-30" id="Fact000117" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:CommonStockValue" contextRef="AsOf2024-12-31" id="Fact000118" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_404_eus-gaap--RetainedEarningsAccumulatedDeficit_i02I_maCzvPr_maSEz7eW_zw9UL53Ep9uj" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Accumulated Deficit</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2025-09-30" id="Fact000140" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,259,139</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:RetainedEarningsAccumulatedDeficit" contextRef="AsOf2024-12-31" id="Fact000141" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,854,174</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--StockholdersEquity_i02TI_mtSEz7eW_maLASEzruk_z05tf8BOKjMi" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Total Shareholders’ Deficit</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30" id="Fact000143" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,258,933</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000144" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,853,968</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_403_eus-gaap--LiabilitiesAndStockholdersEquity_i01TI_mtLASEzruk_z0uRH71X3q1f" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2025-09-30" id="Fact000146" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,620,977</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:LiabilitiesAndStockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000147" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,513,922</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">See
accompanying notes to</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited <span style="background-color: white">financial
statements.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<!-- Field: Page; Sequence: 4 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F-002"></span>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
STATEMENTS OF OPERATIONS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" id="xdx_30B_113_zs49YJhETJ15" summary="xdx: Statement - Statements of Operations (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="2" id="xdx_494_20250701__20250930_zloGizZEfIn9" style="text-align: center">For the three months ended<br/>
September 30,</td><td> </td><td> </td>
<td colspan="2" id="xdx_49A_20240701__20240930_zgXPYYFvRz3d" style="text-align: center">For the three months ended<br/>
September 30,</td><td> </td><td> </td>
<td colspan="2" id="xdx_49D_20250101__20250930_zM29kwC5aFm" style="text-align: center">For the nine months ended<br/>
September 30,</td><td> </td><td> </td>
<td colspan="2" id="xdx_495_20240101__20240930_ztcEE1Xo3LP4" style="text-align: center">For the nine months ended<br/>
September 30,</td><td> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="2" style="text-align: justify"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td></tr>
<tr id="xdx_401_eus-gaap--OperatingExpenses_iN_di_msOILzFHd_z0ryOPg7URKd" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 36%; text-align: left; padding-bottom: 1pt">Formation and operating costs</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1pt; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2025-07-012025-09-30" id="Fact000149" format="ixt:numdotdecimal" decimals="0" unitRef="USD">168,489</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1pt; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-07-012024-09-30" id="Fact000150" format="ixt:numdotdecimal" decimals="0" unitRef="USD">157,610</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1pt; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2025-01-01to2025-09-30" id="Fact000151" format="ixt:numdotdecimal" decimals="0" unitRef="USD">725,875</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="padding-bottom: 1pt; width: 1%; text-align: left">$</td><td style="padding-bottom: 1pt; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:OperatingExpenses" contextRef="From2024-01-012024-09-30" id="Fact000152" format="ixt:numdotdecimal" decimals="0" unitRef="USD">538,462</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td></tr>
<tr id="xdx_407_ecustom--NonredemptionAgreementExpense_iN_di_msOILzFHd_zwm2CCC8PxN1" style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 1pt">Non-redemption agreement expense</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2025-07-012025-09-30" id="Fact000154" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,022</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0155">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2025-01-01to2025-09-30" id="Fact000156" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,022</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0157">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--OperatingIncomeLoss_iT_mtOILzFHd_maNILzhST_z2AS8EehlSvh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Loss from operations</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2025-07-012025-09-30" id="Fact000159" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">331,511</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000160" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">157,610</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2025-01-01to2025-09-30" id="Fact000161" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">888,897</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:OperatingIncomeLoss" contextRef="From2024-01-012024-09-30" id="Fact000162" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">538,462</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_402_eus-gaap--NonoperatingIncomeExpenseAbstract_iB_z2IvUmBbX2A7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Other income:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_408_eus-gaap--InvestmentIncomeDividend_i01_maCzijn_zoVIOQIAyBDb" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left">Dividend income earned on cash and investment held in Trust Account</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2025-07-012025-09-30" id="Fact000169" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,364</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2024-07-012024-09-30" id="Fact000170" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,865</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2025-01-01to2025-09-30" id="Fact000171" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,491</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2024-01-012024-09-30" id="Fact000172" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171,443</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_405_eus-gaap--InterestIncomeOther_i01_maCzijn_zYwEGUPB7PZ1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Interest income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0174">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2024-07-012024-09-30" id="Fact000175" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2025-01-01to2025-09-30" id="Fact000176" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:InterestIncomeOther" contextRef="From2024-01-012024-09-30" id="Fact000177" format="ixt:numdotdecimal" decimals="0" unitRef="USD">22</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40A_eus-gaap--NonoperatingIncomeExpense_i01T_mtCzijn_maNILzhST_z6nWwuHYesp8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Total other income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2025-07-012025-09-30" id="Fact000179" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,364</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-07-012024-09-30" id="Fact000180" format="ixt:numdotdecimal" decimals="0" unitRef="USD">917,872</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2025-01-01to2025-09-30" id="Fact000181" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,492</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NonoperatingIncomeExpense" contextRef="From2024-01-012024-09-30" id="Fact000182" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171,465</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_403_eus-gaap--NetIncomeLoss_iT_mtNILzhST_zhyKJPbgiPQg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">NET (LOSS) INCOME</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30" id="Fact000184" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">242,147</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000185" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30" id="Fact000186" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,595</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-09-30" id="Fact000187" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,633,003</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding, ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zGFhGv8zVc0b" title="Basic weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_905_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zlYsp5pUdsBj" title="Diluted weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-07-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000189" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-07-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000191" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">779,989</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zJQ3eHCdnkma" title="Basic weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zff2SaCvqNX5" title="Diluted weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000193" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000195" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zrGESqWNkDza" title="Basic weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zA1EMzBZdKI3" title="Diluted weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-01-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000197" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-01-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000199" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,016,929</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zAyTHA6IUUWg" title="Basic weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zn7mbo4qz4r4" title="Diluted weighted average shares outstanding, ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000201" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000203" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,540,146</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net (loss) income per ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_903_eus-gaap--EarningsPerShareBasic_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zGPknjedHTha" title="Basic net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zNADEnGCMpb2" title="Diluted net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-07-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000205" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-07-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000207" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zdszRPhSjun7" title="Basic net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_90F_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_z24JTzhpSzvl" title="Diluted net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000209" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000211" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zkMNYUlCOOtd" title="Basic net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_905_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_z6fOaH33S82h" title="Diluted net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-01-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000213" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-01-012025-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000215" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zbBkbHgDkL65" title="Basic net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_903_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--OrdinarySharesSubjectToPossibleRedemptionMember_zhy3hmUWIE8b" title="Diluted net (loss) income per ordinary shares subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000217" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-09-30_custom_OrdinarySharesSubjectToPossibleRedemptionMember" id="Fact000219" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.22</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding, ordinary shares not subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250701__20250930_zJfZoIQVYUlb" title="Basic weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250701__20250930_zKcCFA8EMXti" title="Diluted weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-07-012025-09-30" id="Fact000221" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-07-012025-09-30" id="Fact000223" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240701__20240930_ztRqP5CBdrLd" title="Basic weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_909_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240701__20240930_zY5B45ZE4NQ5" title="Diluted weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30" id="Fact000225" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30" id="Fact000227" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20250101__20250930_zTvt5TcXrpwb" title="Basic weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_902_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20250101__20250930_zSSbtVBr3K9j" title="Diluted weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-01-01to2025-09-30" id="Fact000229" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-01-01to2025-09-30" id="Fact000231" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_pid_c20240101__20240930_zHvSfmyI0lVk" title="Basic weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_pid_c20240101__20240930_znzvrnUOMfIg" title="Diluted weighted average shares outstanding, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-09-30" id="Fact000233" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-09-30" id="Fact000235" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,996,387</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net (loss) income per share, ordinary shares not subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90A_eus-gaap--EarningsPerShareBasic_pid_c20250701__20250930_zYhplgwJRkp9" title="Basic net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20250701__20250930_z0Vk6dz1wAje" title="Diluted net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-07-012025-09-30" id="Fact000237" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-07-012025-09-30" id="Fact000239" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930_zX6TMb8beeg3" title="Basic net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_909_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930_zqehARZ8A9bl" title="Diluted net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30" id="Fact000241" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30" id="Fact000243" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_905_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250930_zAlhRl3nGO5k" title="Basic net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_90A_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250930_zjlaa2qiNqPa" title="Diluted net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-01-01to2025-09-30" id="Fact000245" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-01-01to2025-09-30" id="Fact000247" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240930_zBA77Oa3yOih" title="Basic net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930_zM4hC9Fj2URk" title="Diluted net (loss) income per share, ordinary shares not subject to possible redemption" class="xdx_phnt_U3RhdGVtZW50IC0gU3RhdGVtZW50cyBvZiBPcGVyYXRpb25zIChVbmF1ZGl0ZWQpAA__"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-09-30" id="Fact000249" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-09-30" id="Fact000251" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.22</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">See
accompanying notes to </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited <span style="background-color: white">financial
statements.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 5 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F-003"></span>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<table cellpadding="0" cellspacing="0" id="xdx_309_114_zss1eqZ2pgZj" summary="xdx: Statement - Statements of Changes in Shareholders' Deficit (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="display: none; vertical-align: bottom">
<td style="padding-left: 0pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_4B8_us-gaap--StatementEquityComponentsAxis_us-gaap--CommonStockMember_zel0ol0zAbca" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_4BE_us-gaap--StatementEquityComponentsAxis_us-gaap--AdditionalPaidInCapitalMember_zKi20rXYTFXc" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_4BF_us-gaap--StatementEquityComponentsAxis_us-gaap--RetainedEarningsMember_zSO5Rqf6gOsl" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_4BF_zOLlHqJyzOZe" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 0pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="18" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2025</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 0pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Ordinary shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="padding-bottom: 1pt; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 0pt; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">No. of shares</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Additional paid-in capital</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated deficit</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">shareholders’ <br/>deficit</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td>
<td> </td></tr>
<tr id="xdx_43E_c20250101__20250331_eus-gaap--StockholdersEquity_iS_zk2GV0yiLbwf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-left: 0pt; width: 30%">Balance as of December 31, 2024</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left"> </td><td id="xdx_98C_eus-gaap--SharesOutstanding_iS_pid_c20250101__20250331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zkhq2VpsBEVg" title="Balance, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000258" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_CommonStockMember" id="Fact000253" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">    <span style="-sec-ix-hidden: xdx2ixbrl0254">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31_us-gaap_RetainedEarningsMember" id="Fact000255" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,854,174</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-12-31" id="Fact000256" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,853,968</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_405_ecustom--ExtensionFundsAttributableToCommonStockSubjectToRedemption_iN_di_zQLs7aJDx8Jj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Extension funds attributable to ordinary shares subject to redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0260">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0261">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember" id="Fact000262" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,949</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-01-012025-03-31" id="Fact000263" format="ixt:numdotdecimal" decimals="0" unitRef="USD">357,949</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_402_ecustom--RemeasurementOfOrdinarySharesSubjectToPossibleRedemption_iN_di_zlgJnStpPXEk" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left">Remeasurement of ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0265">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0266">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember" id="Fact000267" format="ixt:numdotdecimal" decimals="0" unitRef="USD">740,346</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-01-012025-03-31" id="Fact000268" format="ixt:numdotdecimal" decimals="0" unitRef="USD">740,346</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--NetIncomeLoss_zbGstKkIaKL1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0270">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0271">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-03-31_us-gaap_RetainedEarningsMember" id="Fact000272" format="ixt:numdotdecimal" decimals="0" unitRef="USD">452,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-03-31" id="Fact000273" format="ixt:numdotdecimal" decimals="0" unitRef="USD">452,085</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_437_c20250401__20250630_eus-gaap--StockholdersEquity_iS_zggfWIPD7Ul" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Balance as of March 31, 2025</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20250401__20250630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn2Qir3NOiCc" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" id="Fact000280" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-03-31_us-gaap_CommonStockMember" id="Fact000275" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0276">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-03-31_us-gaap_RetainedEarningsMember" id="Fact000277" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,500,384</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-03-31" id="Fact000278" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,500,178</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_ecustom--ExtensionFundsAttributableToCommonStockSubjectToRedemption_iN_di_zilv06Hckksc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Extension funds attributable to ordinary shares subject to redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0282">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0283">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember" id="Fact000284" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,142</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-04-012025-06-30" id="Fact000285" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,142</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--RemeasurementOfOrdinarySharesSubjectToPossibleRedemption_iN_di_zFTwdCQW7S72" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left">Remeasurement of ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0287">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0288">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember" id="Fact000289" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,781</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-04-012025-06-30" id="Fact000290" format="ixt:numdotdecimal" decimals="0" unitRef="USD">503,781</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_404_eus-gaap--NetIncomeLoss_znh9kadHvh2a" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0292">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0293">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-04-012025-06-30_us-gaap_RetainedEarningsMember" id="Fact000294" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,657</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-04-012025-06-30" id="Fact000295" format="ixt:numdotdecimal" decimals="0" unitRef="USD">234,657</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_43A_c20250701__20250930_eus-gaap--StockholdersEquity_iS_zFI6vZTTmIi3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Balance as of June 30, 2025</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_985_eus-gaap--SharesOutstanding_iS_pid_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zV8tF0CaVIic" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000302" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_CommonStockMember" id="Fact000297" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0298">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30_us-gaap_RetainedEarningsMember" id="Fact000299" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,970,650</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-06-30" id="Fact000300" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,970,444</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_ecustom--ExtensionFundsAttributableToCommonStockSubjectToRedemption_iN_di_z3Gab5K06MD" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Extension funds attributable to ordinary shares subject to redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0304">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0305">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-07-012025-09-30_us-gaap_RetainedEarningsMember" id="Fact000306" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,000</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionFundsAttributableToCommonStockSubjectToRedemption" contextRef="From2025-07-012025-09-30" id="Fact000307" format="ixt:numdotdecimal" decimals="0" unitRef="USD">120,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_ecustom--RemeasurementOfOrdinarySharesSubjectToPossibleRedemption_iN_di_z2YBPdQtKhll" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left">Remeasurement of ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0309">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0310">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-07-012025-09-30_us-gaap_RetainedEarningsMember" id="Fact000311" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,364</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:RemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-07-012025-09-30" id="Fact000312" format="ixt:numdotdecimal" decimals="0" unitRef="USD">89,364</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_406_ecustom--ContributionNonredemptionAgreement_iN_di_zpIIle0SlhOc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left">Contribution - non-redemption agreement</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:ContributionNonredemptionAgreement" contextRef="From2025-07-012025-09-30_us-gaap_RetainedEarningsMember" id="Fact000316" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">163,022</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:ContributionNonredemptionAgreement" contextRef="From2025-07-012025-09-30" id="Fact000317" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">163,022</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_zbhgEnrqrIT4" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 0pt; text-align: left; padding-bottom: 1pt">Net loss</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0319">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0320">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30_us-gaap_RetainedEarningsMember" id="Fact000321" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">242,147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30" id="Fact000322" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">242,147</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 0pt; text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_432_c20250701__20250930_eus-gaap--StockholdersEquity_iE_z0UO68wXUDHg" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-left: 0pt; padding-bottom: 2.5pt">Balance as of September 30, 2025</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_98D_eus-gaap--SharesOutstanding_iE_pid_c20250701__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsTlkDZd1k1l" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" id="Fact000329" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" id="Fact000324" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30_us-gaap_RetainedEarningsMember" id="Fact000326" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,259,139</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2025-09-30" id="Fact000327" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,258,933</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="18" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended September 30, 2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">Ordinary shares</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="padding-bottom: 1pt; text-align: center">Total</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">No. of shares</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Amount</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Additional paid-in capital</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Accumulated deficit</td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">shareholders’ <br/>deficit</td><td style="text-align: center; padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td style="text-align: left"> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td><td> </td>
<td colspan="2" style="text-align: right"> </td><td> </td></tr>
<tr id="xdx_431_c20240101__20240331_eus-gaap--StockholdersEquity_iS_zcPBxvpKWN07" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; width: 30%">Balance as of December 31, 2023</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--SharesOutstanding_iS_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z71eTf5pBmTj" title="Balance, shares" style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000336" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_CommonStockMember" id="Fact000331" format="ixt:numdotdecimal" decimals="0" unitRef="USD">173</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000332" format="ixt:numdotdecimal" decimals="0" unitRef="USD">24,827</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31_us-gaap_RetainedEarningsMember" id="Fact000333" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">168,597</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2023-12-31" id="Fact000334" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">143,597</ix:nonFraction></td><td style="width: 1%; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_400_eus-gaap--StockIssuedDuringPeriodValueNewIssues_zcJIWYb6Qtd5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Sale of units in initial public offering, net of offering costs</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_98D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCyLjxR4ZmQa" title="Sale of units in initial public offering, net of offering costs, shares" style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000343" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000338" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000339" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,023,204</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0340">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-01-012024-03-31" id="Fact000341" format="ixt:numdotdecimal" decimals="0" unitRef="USD">66,023,894</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_ecustom--StockIssuedDuringPeriodValuePrivatePlacement_zhxSYaScn93k" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Sale of units to the founder in private placement</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_987_ecustom--StockIssuedDuringPeriodSharesPrivatePlacement_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zUabhwqWQTPl" title="Sale of units to the founder in private placement, shares" style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodSharesPrivatePlacement" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000350" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">234,500</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000345" format="ixt:numdotdecimal" decimals="0" unitRef="USD">23</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000346" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,344,977</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0347">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValuePrivatePlacement" contextRef="From2024-01-012024-03-31" id="Fact000348" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,345,000</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_401_ecustom--StockIssuedDuringPeriodValueRepresentativeShare_zmRd0X3Dilrf" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Issuance of representative shares</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_98B_ecustom--StockIssuedDuringPeriodSharesRepresentativeShare_pid_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zlGFU4I1W4Ge" title="Issuance of representative shares, shares" style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodSharesRepresentativeShare" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000357" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,500</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValueRepresentativeShare" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000352" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:StockIssuedDuringPeriodValueRepresentativeShare" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000353" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0354">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0355">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_iN_di_zew7WnJP4Tf1" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Initial classification of ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_987_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_iN_pid_di_c20240101__20240331__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zhyfSdFKSWle" title="Initial classification of ordinary shares subject to possible redemption, shares" style="text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000364" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_CommonStockMember" id="Fact000359" format="ixt:numdotdecimal" decimals="0" unitRef="USD">690</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000360" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,013,596</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2024-01-012024-03-31" id="Fact000362" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,014,286</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock_zPNGeBHBcqV8" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Allocation of offering costs to ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0366">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000367" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,933,590</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0368">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfRedeemablePreferredStock" contextRef="From2024-01-012024-03-31" id="Fact000369" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,933,590</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_ecustom--AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfAccretionOfCarryingValueToRedemptionValue_z5W48HFQoqL9" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Accretion of carrying value to redemption value</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0371">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfAccretionOfCarryingValueToRedemptionValue" contextRef="From2024-01-012024-03-31_us-gaap_AdditionalPaidInCapitalMember" id="Fact000372" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">3,312,992</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfAccretionOfCarryingValueToRedemptionValue" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000373" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">951,312</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:AdjustmentsToAdditionalPaidInCapitalIncreaseInCarryingAmountOfAccretionOfCarryingValueToRedemptionValue" contextRef="From2024-01-012024-03-31" id="Fact000374" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">4,264,304</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_ecustom--SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption_zr8FD9e2sdu4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Subsequent remeasurement of ordinary shares subject to possible redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0377">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000378" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">346,250</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-012024-03-31" id="Fact000379" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">346,250</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--NetIncomeLoss_zAD32gre9bWb" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31_us-gaap_RetainedEarningsMember" id="Fact000383" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-03-31" id="Fact000384" format="ixt:numdotdecimal" decimals="0" unitRef="USD">43,875</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_430_c20240401__20240630_eus-gaap--StockholdersEquity_iS_zxeqK27BkSZ3" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Balance as of March 31, 2024</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_98B_eus-gaap--SharesOutstanding_iS_pid_c20240401__20240630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z1LR8QJSAQ1e" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000391" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_CommonStockMember" id="Fact000386" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31_us-gaap_RetainedEarningsMember" id="Fact000388" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,422,284</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-03-31" id="Fact000389" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,422,078</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40C_ecustom--SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption_zFcxXyy4iH71" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Subsequent remeasurement of ordinary shares subject to redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000395" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">907,328</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-04-012024-06-30" id="Fact000396" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">907,328</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLoss_zDSDwSFXztW2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0398">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0399">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30_us-gaap_RetainedEarningsMember" id="Fact000400" format="ixt:numdotdecimal" decimals="0" unitRef="USD">828,866</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-04-012024-06-30" id="Fact000401" format="ixt:numdotdecimal" decimals="0" unitRef="USD">828,866</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_437_c20240701__20240930_eus-gaap--StockholdersEquity_iS_z9K6IT6k8SMi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Balance as of June 30, 2024</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_98E_eus-gaap--SharesOutstanding_iS_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z2hmBFjat0ic" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000408" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000403" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000405" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,746</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000406" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,540</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_43A_c20240701__20240930_eus-gaap--StockholdersEquity_iS_zwpWPLzmtUB6" style="display: none; vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Balance</td><td> </td>
<td style="text-align: left"> </td><td id="xdx_984_eus-gaap--SharesOutstanding_iS_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zaQy7ordGxYb" title="Balance, shares" style="text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000415" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_CommonStockMember" id="Fact000410" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0411">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30_us-gaap_RetainedEarningsMember" id="Fact000412" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,746</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-06-30" id="Fact000413" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,500,540</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40C_ecustom--SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption_z2w43IoQUqV7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Subsequent remeasurement of ordinary shares subject to redemption</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">-</td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0417">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000419" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">917,865</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-07-012024-09-30" id="Fact000420" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">917,865</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40A_eus-gaap--NetIncomeLoss_zNOZBAYGukul" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Net income</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0422">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0423">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000424" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000425" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr id="xdx_409_eus-gaap--NetIncomeLoss_zIUrfI6F3Cok" style="display: none; vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Net income (loss)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">-</td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0428">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_us-gaap_RetainedEarningsMember" id="Fact000429" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000430" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_43C_c20240701__20240930_eus-gaap--StockholdersEquity_iE_zszOl4pEqn7g" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Balance as of September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_980_eus-gaap--SharesOutstanding_iE_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE0UqCVr60a8" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000437" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000432" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0433">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000434" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,658,349</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000435" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,658,143</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
<tr id="xdx_435_c20240701__20240930_eus-gaap--StockholdersEquity_iE_zBppQY9SL4q1" style="display: none; vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Balance</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left"> </td><td id="xdx_982_eus-gaap--SharesOutstanding_iE_pid_c20240701__20240930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zNdErH2GkCTl" title="Balance, shares" style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:SharesOutstanding" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000444" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_CommonStockMember" id="Fact000439" format="ixt:numdotdecimal" decimals="0" unitRef="USD">206</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30_us-gaap_RetainedEarningsMember" id="Fact000441" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,658,349</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(<ix:nonFraction name="us-gaap:StockholdersEquity" contextRef="AsOf2024-09-30" id="Fact000442" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,658,143</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">See
accompanying notes to </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited <span style="background-color: white">financial
statements.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 6 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F-004"></span>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>UNAUDITED
STATEMENTS OF CASH FLOWS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; text-indent: 1.75pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" id="xdx_30C_112_zaQr5GwjCbi7" summary="xdx: Statement - Statements of Cash Flows (Unaudited)" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td style="text-align: center"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_495_20250101__20250930_zfA1JyKKSgbg" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the nine</p>
<p style="margin-top: 0; margin-bottom: 0">months ended <br/>September 30, 2025</p></td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_498_20240101__20240930_zEIlIZjO3Ihj" style="border-bottom: Black 1pt solid; text-align: center"><p style="margin-top: 0; margin-bottom: 0">For the nine</p>
<p style="margin-top: 0; margin-bottom: 0">months ended <br/>September 30, 2024</p></td><td style="padding-bottom: 1pt"> </td></tr>
<tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInOperatingActivitiesAbstract_iB_zlP04XFb35Lh" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Cash flows from operating activities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td style="font-weight: bold"> </td>
<td style="font-weight: bold; text-align: left"> </td><td style="font-weight: bold; text-align: right"> </td><td style="font-weight: bold; text-align: left"> </td></tr>
<tr id="xdx_406_eus-gaap--NetIncomeLoss_i01_maNCPBUz1BM_zvfgQn9KZgEk" style="vertical-align: bottom; background-color: White">
<td style="width: 62%; text-align: left">Net income</td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30" id="Fact000449" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,595</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td>
<td style="width: 1%; text-align: left">$</td><td style="width: 15%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-09-30" id="Fact000450" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,633,003</ix:nonFraction></td><td style="width: 1%; text-align: left"> </td></tr>
<tr id="xdx_400_eus-gaap--AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_i01B_zzHY1vdS6Mq3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Adjustments to reconcile net income to net cash used in operating activities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_405_eus-gaap--InvestmentIncomeDividend_i02N_di_msNCPBUz1BM_zKTScNPomkoj" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Dividend income earned on cash and investment held in trust account</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2025-01-01to2025-09-30" id="Fact000455" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,491</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:InvestmentIncomeDividend" contextRef="From2024-01-012024-09-30" id="Fact000456" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171,443</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40C_ecustom--NonredemptionAgreementExpense_i02_maNCPBUz1BM_z5X080YL9JKl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Non-redemption agreement expense</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2025-01-01to2025-09-30" id="Fact000458" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,022</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--IncreaseDecreaseInOperatingCapitalAbstract_i02B_z9XNZowQwJDg" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Change in operating assets and liabilities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInPrepaidExpense_i03N_di_msNCPBUz1BM_z2aDSrdBrTi1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 10pt; text-align: left">Prepaid expenses</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2025-01-01to2025-09-30" id="Fact000464" format="ixt:numdotdecimal" decimals="0" unitRef="USD">6,041</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInPrepaidExpense" contextRef="From2024-01-012024-09-30" id="Fact000465" format="ixt:numdotdecimal" decimals="0" unitRef="USD">29,495</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_40E_eus-gaap--IncreaseDecreaseInDueToRelatedParties_i03_maNCPBUz1BM_zn5JFt1RoTei" style="vertical-align: bottom; background-color: White">
<td style="padding-left: 10pt; text-align: left">Due to related party</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2025-01-01to2025-09-30" id="Fact000467" format="ixt:numdotdecimal" decimals="0" unitRef="USD">110,551</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInDueToRelatedParties" contextRef="From2024-01-012024-09-30" id="Fact000468" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">147,614</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--IncreaseDecreaseInAccruedLiabilities_i03_maNCPBUz1BM_zHVstVoEhDAg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-left: 10pt; text-align: left; padding-bottom: 1pt">Accrued liabilities</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2025-01-01to2025-09-30" id="Fact000470" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">26,379</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:IncreaseDecreaseInAccruedLiabilities" contextRef="From2024-01-012024-09-30" id="Fact000471" format="ixt:numdotdecimal" decimals="0" unitRef="USD">44,363</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40C_eus-gaap--NetCashProvidedByUsedInOperatingActivities_i01T_mtNCPBUz1BM_maCCERCzmy8_zYua3fkYpyFl" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 1pt">Net cash used in operating activities</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2025-01-01to2025-09-30" id="Fact000473" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">647,743</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInOperatingActivities" contextRef="From2024-01-012024-09-30" id="Fact000474" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">671,186</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_408_eus-gaap--NetCashProvidedByUsedInInvestingActivitiesAbstract_iB_zH7mXR071eN5" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold; text-align: left">Cash flows from investing activities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40A_eus-gaap--PaymentsForProceedsFromOtherDeposits_i01N_di_msNCPBUzor8_zqEnFQhmMa0b" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Proceeds deposited in Trust Account</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0479">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsForProceedsFromOtherDeposits" contextRef="From2024-01-012024-09-30" id="Fact000480" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,345,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_401_ecustom--ExtensionPaymentsDepositedInTrustAccount_i01N_di_msNCPBUzor8_zTcIItLBWkD3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Extension payments deposited in Trust Account</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="DYCQ:ExtensionPaymentsDepositedInTrustAccount" contextRef="From2025-01-01to2025-09-30" id="Fact000482" format="ixt:numdotdecimal" decimals="0" unitRef="USD">679,091</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40E_eus-gaap--ProceedsFromSaleAndCollectionOfReceivables_i01_maNCPBUzor8_z8jvHsfEFxO8" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Cash withdrawn from Trust Account in connection to redemption</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromSaleAndCollectionOfReceivables" contextRef="From2025-01-01to2025-09-30" id="Fact000485" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,759,547</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0486">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_400_eus-gaap--NetCashProvidedByUsedInInvestingActivities_i01T_mtNCPBUzor8_maCCERCzmy8_zMWdhrzOR4x2" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) investing activities</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2025-01-01to2025-09-30" id="Fact000488" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,080,456</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInInvestingActivities" contextRef="From2024-01-012024-09-30" id="Fact000489" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">69,345,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40A_eus-gaap--NetCashProvidedByUsedInFinancingActivitiesAbstract_iB_zCDbHQoCdKBh" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">Cash flows from financing activities:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_404_eus-gaap--PaymentsOfDividendsCommonStock_i01N_di_msNCPBUzKWX_zOk4VaFTuyCj" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td>Redemption of ordinary shares</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:PaymentsOfDividendsCommonStock" contextRef="From2025-01-01to2025-09-30" id="Fact000494" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,759,547</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_408_eus-gaap--ProceedsFromRepaymentsOfRelatedPartyDebt_i01_maNCPBUzKWX_z32G4ll6HLO" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Advances from (repayment to) related parties</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2025-01-01to2025-09-30" id="Fact000497" format="ixt:numdotdecimal" decimals="0" unitRef="USD">159,488</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt" contextRef="From2024-01-012024-09-30" id="Fact000498" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">490,000</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr id="xdx_407_eus-gaap--ProceedsFromOtherDebt_i01_maNCPBUzKWX_zL0E2F1segF1" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Proceeds from other payable</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromOtherDebt" contextRef="From2025-01-01to2025-09-30" id="Fact000500" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0501">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_400_eus-gaap--ProceedsFromNotesPayable_i01_maNCPBUzKWX_zFG1SzCfHVfh" style="vertical-align: bottom; background-color: White">
<td style="text-align: left">Proceeds from promissory notes</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromNotesPayable" contextRef="From2025-01-01to2025-09-30" id="Fact000503" format="ixt:numdotdecimal" decimals="0" unitRef="USD">715,325</ix:nonFraction></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0504">-</span></td><td style="text-align: left"> </td></tr>
<tr id="xdx_40B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_i01_maNCPBUzKWX_zWYIyLsKZpj7" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Proceeds from public offering, net of offering costs</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0506">-</span></td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2024-01-012024-09-30" id="Fact000507" format="ixt:numdotdecimal" decimals="0" unitRef="USD">67,833,894</ix:nonFraction></td><td style="text-align: left"> </td></tr>
<tr id="xdx_404_eus-gaap--ProceedsFromIssuanceOfPrivatePlacement_i01_maNCPBUzKWX_zuIGSdwlZzaa" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Proceeds from private placement</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0509">-</span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfPrivatePlacement" contextRef="From2024-01-012024-09-30" id="Fact000510" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,345,000</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_401_eus-gaap--NetCashProvidedByUsedInFinancingActivities_i01T_mtNCPBUzKWX_maCCERCzmy8_zA8InxUfn2nf" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 1pt">Net cash provided by (used in) financing activities</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(<ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2025-01-01to2025-09-30" id="Fact000512" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">71,584,734</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:NetCashProvidedByUsedInFinancingActivities" contextRef="From2024-01-012024-09-30" id="Fact000513" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,688,894</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40F_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_iT_mtCCERCzmy8_zUIxm0QxweDi" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">NET CHANGE IN CASH</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2025-01-01to2025-09-30" id="Fact000515" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">152,021</ix:nonFraction></td><td style="text-align: left">)</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right">(<ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" contextRef="From2024-01-012024-09-30" id="Fact000516" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">327,292</ix:nonFraction></td><td style="text-align: left">)</td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_405_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iS_zMGhVbJgshj7" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left; padding-bottom: 1pt">CASH, BEGINNING OF YEAR</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-12-31" id="Fact000518" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,021</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2023-12-31" id="Fact000519" format="ixt:numdotdecimal" decimals="0" unitRef="USD">494,818</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_404_eus-gaap--CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_iE_zLYBU0KnapJf" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt">CASH, END OF YEAR</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0521">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" contextRef="AsOf2024-09-30" id="Fact000522" format="ixt:numdotdecimal" decimals="0" unitRef="USD">167,526</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_403_eus-gaap--NoncashInvestingAndFinancingItemsAbstract_iB_zD3SYXhlLaSi" style="vertical-align: bottom; background-color: White">
<td style="font-weight: bold; text-align: left">NON-CASH INVESTING AND FINANCING ACTIVITIES:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_407_ecustom--IssuanceOfRepresentativeShare_i01_z5StK1ipy3p9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 2.5pt">Issuance of representative shares</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0527">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:IssuanceOfRepresentativeShare" contextRef="From2024-01-012024-09-30" id="Fact000528" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_40B_ecustom--InitialClassificationOfCommonStockSubjectToPossibleRedemption_i01_zL4kNIPtRVtb" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Initial classification of ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0530">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:InitialClassificationOfCommonStockSubjectToPossibleRedemption" contextRef="From2024-01-012024-09-30" id="Fact000531" format="ixt:numdotdecimal" decimals="0" unitRef="USD">68,014,286</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_400_ecustom--AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption_i01_zUHX58uLHjwg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 2.5pt">Allocation of offering costs to ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0533">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption" contextRef="From2024-01-012024-09-30" id="Fact000534" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,933,590</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_409_ecustom--AccretionOfCarryingValueToRedemptionValue_i01_zdwrgQq9Dsig" style="vertical-align: bottom; background-color: White">
<td style="padding-bottom: 2.5pt">Accretion of carrying value to redemption value</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0536">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:AccretionOfCarryingValueToRedemptionValue" contextRef="From2024-01-012024-09-30" id="Fact000537" format="ixt:numdotdecimal" decimals="0" unitRef="USD">4,264,304</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_408_ecustom--ExtensionFundsAttributableToOrdinarySharesSubjectToRedemption_i01_z6VZiT7YQNE9" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 2.5pt">Extension funds attributable to ordinary shares subject to redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:ExtensionFundsAttributableToOrdinarySharesSubjectToRedemption" contextRef="From2025-01-01to2025-09-30" id="Fact000539" format="ixt:numdotdecimal" decimals="0" unitRef="USD">679,091</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0540">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_400_ecustom--SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption_i01_z9SJCDeLRqvh" style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Subsequent remeasurement of ordinary shares subject to possible redemption</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2025-01-01to2025-09-30" id="Fact000542" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,333,491</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:SubsequentRemeasurementOfOrdinarySharesSubjectToPossibleRedemption" contextRef="From2024-01-012024-09-30" id="Fact000543" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,171,443</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr id="xdx_408_ecustom--AccruedUnderwritingCompensation_i01_z8pvcDXLMkL6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left; padding-bottom: 2.5pt">Accrued underwriting compensation</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><ix:nonFraction name="DYCQ:AccruedUnderwritingCompensation" contextRef="From2024-01-012024-09-30" id="Fact000546" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">See
accompanying notes to</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unaudited <span style="background-color: white">financial
statements.</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 7 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="F-005"></span>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000548" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"><p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zQ7Cyi1HMDbd" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
1 - <span id="xdx_82E_zvh7jRIW3o79">ORGANIZATION AND BUSINESS BACKGROUND</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">DT
Cloud Acquisition Corporation (the “Company”) is an incorporated blank check company incorporated as a Cayman Islands exempted
company on July 7, 2022, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar business combination with one or more businesses (the “Business Combination”). The Company is not limited to a
particular industry or geographic region for purposes of consummating a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025, the Company has not commenced any operations. All activities through September 30, 2025 relate to the Company’s
formation and the initial public offering (the “Initial Public Offering” or “IPO”). Since the Initial Public
Offering, the Company’s activity has been limited to the evaluation of business combination candidates. The Company will not generate
any operating revenues until after the completion of a Business Combination, at the earliest. The Company will generate non-operating
income in the form of interest income and dividend income on cash and investments held in the trust account. The Company has selected
December 31 as its fiscal year end.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Financing</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
registration statement for the Company’s Initial Public Offering was declared effective on February 14, 2024. On February 23, 2024,
the Company consummated the Initial Public Offering of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z09Sy9ztyVD3" title="Initial public offering in units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000550" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> units (the “Public Units”), which includes <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicUnitsMember_z4XTn4iKpoD9" title="Initial public offering in units, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2024-02-232024-02-23_custom_PublicUnitsMember" id="Fact000552" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Public
Units upon the full exercise by the underwriter of its over-allotment option, at $<span id="xdx_90D_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z7aJXEYEQX27" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-02-23_us-gaap_IPOMember" id="Fact000554" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Public Unit, generating gross proceeds of
$<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJ9Pe9FBYWl6" title="Proceeds from issuance initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000556" format="ixt:numdotdecimal" decimals="0" unitRef="USD">69,000,000</ix:nonFraction></span> to the Company. Each Public Unit consists of one ordinary share and one right (“Public Rights”). Each whole Public
Right will entitle the holder to receive one-seventh (1/7) ordinary share upon consummation of initial business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated the sale of <span id="xdx_907_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementUnitsMember_zKlSGd9DGyyf" title="Sale of initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-02-232024-02-23_custom_PrivatePlacementUnitsMember" id="Fact000558" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">234,500</ix:nonFraction></span> units (the “Private Placement Units”)
at a price of $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementUnitsMember_zUu6TmBFNKnk" title="Sale of stock price"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-02-23_custom_PrivatePlacementUnitsMember" id="Fact000560" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit in a private placement to DT Cloud Capital Corp. (the “Sponsor”), generating
gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PrivatePlacementUnitsMember_zg85azxdVox" title="Proceeds from issuance initial public offering"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" contextRef="From2024-02-232024-02-23_custom_PrivatePlacementUnitsMember" id="Fact000562" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,345,000</ix:nonFraction></span> to the Company. Each Private Placement Unit consists of one Private Placement Share and one right (“Private
Placement Right”). Each Private Placement Right will entitle the holder to receive one-seventh (1/7) ordinary share upon consummation
of the initial business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction
costs amounted to $<span id="xdx_90F_ecustom--TransactionCosts_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_z8KTwBdm4LPk" title="Transaction costs"><ix:nonFraction name="DYCQ:TransactionCosts" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000564" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,976,106</ix:nonFraction></span>, consisting of $<span id="xdx_905_eus-gaap--PaymentsForUnderwritingExpense_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_ziceZuwU7ta" title="Underwriting commissions"><ix:nonFraction name="us-gaap:PaymentsForUnderwritingExpense" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000566" format="ixt:numdotdecimal" decimals="0" unitRef="USD">966,000</ix:nonFraction></span> of underwriting commissions, $<span id="xdx_901_ecustom--DeferredUnderwritingCommissions_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zt44KiSjlx1c" title="Deferred underwriting commissions"><ix:nonFraction name="DYCQ:DeferredUnderwritingCommissions" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000568" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></span> of deferred underwriting commissions and
$<span id="xdx_901_eus-gaap--DeferredOfferingCosts_iI_c20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zCiDgShEyya1" title="Deferred offering costs"><ix:nonFraction name="us-gaap:DeferredOfferingCosts" contextRef="AsOf2024-02-23_us-gaap_IPOMember" id="Fact000570" format="ixt:numdotdecimal" decimals="0" unitRef="USD">285,106</ix:nonFraction></span> of other offering costs</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Trust
Account</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
the closing of the Initial Public Offering, an aggregate amount of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicUnitsMember_z9czenwdPS99" title="Initial public offering in units"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodValueNewIssues" contextRef="From2024-02-232024-02-23_custom_PublicUnitsMember" id="Fact000572" format="ixt:numdotdecimal" decimals="INF" unitRef="USD">69,345,000</ix:nonFraction></span> ($<span id="xdx_908_eus-gaap--SharePrice_iI_pid_c20240223__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicUnitsMember_zcUQLmj2rGmi" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2024-02-23_custom_PublicUnitsMember" id="Fact000574" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span> per Public Unit) placed in the Company’s
trust account (“Trust Account”) established for the benefit of the Company’s public shareholders and maintained by
Continental Stock Transfer & Trust Company, acting as trustee, will be invested only in U.S. government treasury bills, with a maturity
of 185 days or less or in money market funds investing solely in U.S. Treasuries and meeting certain conditions under Rule 2a-7 under
the Investment Company Act of 1940, as amended (the “Investment Company Act”). Except with respect to interest earned on
the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the funds in the Trust Account will
not be released until the earliest of (i) the completion of the Company’s initial Business Combination, (ii) the redemption of
any public shares properly tendered in connection with a shareholder vote to amend the Company’s Amended and Restated Memorandum
and Articles of Association to (A) modify the substance or timing of the Company’s obligation to redeem <span id="xdx_908_ecustom--PercentOfObligationToRedeemPublicShares_iI_pid_dp_uPure_c20250930_zHWHEpI2pDdk" title="Percent of obligation to redeem public shares"><ix:nonFraction name="DYCQ:PercentOfObligationToRedeemPublicShares" contextRef="AsOf2025-09-30" id="Fact000576" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of its public shares
if the Company does not complete its initial Business Combination within 9 months from the closing of the Initial Public Offering (or
up to 21 months from the closing of the Initial Public Offering if the Company extends the period of time to consummate a Business Combination)
or (B) with respect to any other provision relating to shareholders’ rights or pre-business combination activity and (iii) the
redemption of all of the Company’s public shares if the Company is unable to complete its initial Business Combination within nine
months from the closing of the Initial Public Offering (or up to 21 months from the closing of the Initial Public Offering if the Company
extends the period of time to consummate a Business Combination), subject to applicable law.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 8 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
Combination</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering
and sale of the Private Placement Units, although substantially all of the net proceeds are intended to be applied generally toward consummating
a Business Combination. Nasdaq rules provide that the Business Combination must be with one or more target businesses that together have
a fair market value equal to at least <span id="xdx_908_ecustom--PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance_pid_dp_uPure_c20250101__20250930__srt--RangeAxis__srt--MinimumMember_zpSLX1ZFesDl" title="Percentage of fair market value of business acquisition"><ix:nonFraction name="DYCQ:PercentageOfFairMarketValueOfBusinessAcquisitionToTrustAccountBalance" contextRef="From2025-01-012025-09-30_srt_MinimumMember" id="Fact000578" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>% of the balance in the Trust Account (less any deferred underwriting commissions and taxes payable
on interest earned) at the time of the signing of an agreement to enter into a Business Combination. The Company will only complete a
Business Combination if the post-Business Combination company owns or acquires <span id="xdx_909_eus-gaap--BusinessAcquisitionPercentageOfVotingInterestsAcquired_iI_pid_dp_uPure_c20250930__us-gaap--BusinessAcquisitionAxis__custom--PostBusinessCombinationMember_zB2Pi2qYq8F8" title="Percentage of voting interests acquired"><ix:nonFraction name="us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired" contextRef="AsOf2025-09-30_custom_PostBusinessCombinationMember" id="Fact000580" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">50</ix:nonFraction></span>% or more of the outstanding voting securities of the
target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company
under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will provide its shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of a
Business Combination either (i) in connection with a shareholder meeting called to approve the Business Combination or (ii) by means
of a tender offer. In connection with an initial Business Combination, the Company may seek shareholder approval of a Business Combination
at a meeting called for such purpose at which shareholders may seek to redeem their shares, regardless of whether they vote for or against
a Business Combination. The Company shall not consummate such Business Combination unless the Company has net tangible assets of at least
$<span id="xdx_901_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20250930__srt--RangeAxis__srt--MinimumMember_zGIXuZqD1Nn5" title="Business combination, net tangible assets"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2025-09-30_srt_MinimumMember" id="Fact000582" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span> after payment of the deferred underwriting commissions, either immediately prior to, or upon such consummation of, or any
greater net tangible asset or cash requirement that may be contained in the agreement relating to, such Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing, if the Company seeks shareholder approval of a Business Combination and it does not conduct redemptions pursuant to the
tender offer rules, the Company’s Amended and Restated Memorandum and Articles of Association provides that a public shareholder,
together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group”
(as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted
from seeking redemption rights with respect to <span id="xdx_90F_ecustom--PercentageOfRedemptionRights_iI_pid_dp_uPure_c20250930_zMHcAaapMF4j" title="Percentage of redemption rights"><ix:nonFraction name="DYCQ:PercentageOfRedemptionRights" contextRef="AsOf2025-09-30" id="Fact000584" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span>% or more of the public shares without the Company’s prior written consent.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business or other legal reasons, the
Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption pursuant to the tender
offer rules of the Securities and Exchange Commission (“SEC”), and file tender offer documents containing substantially the
same information as would be included in a proxy statement with the SEC prior to completing a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
shareholders will be entitled to redeem their public shares for a pro rata portion of the amount then in the Trust Account (initially
$<span id="xdx_903_eus-gaap--SharePrice_iI_pid_c20250930__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicUnitsMember_zxem0FnrBtyg" title="Share price"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-09-30_custom_PublicUnitsMember" id="Fact000586" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span> per public share, subject to increase of up to an additional $<span id="xdx_907_ecustom--AdditionalSharePrice_iI_pid_c20250930__us-gaap--SubsidiarySaleOfStockAxis__custom--PublicUnitsMember_zIRAL2SSr5A3" title="Additional share price"><ix:nonFraction name="DYCQ:AdditionalSharePrice" contextRef="AsOf2025-09-30_custom_PublicUnitsMember" id="Fact000588" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per public share per month in the event that the Sponsor elects
to extend the period of time to consummate a Business Combination (see below), plus any pro rata interest earned on the funds held in
the Trust Account and not previously released to the Company to pay its tax obligations). The per-share amount to be distributed to shareholders
who redeem their public shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriter (as
discussed in Note 9). There will be no redemption rights upon the completion of a Business Combination with respect to the Company’s
rights. The ordinary shares will be recorded at redemption value and classified as temporary equity upon the completion of the Initial
Public Offering, in accordance with ASC Topic 480 “<i>Distinguishing Liabilities from Equity</i>” (“ASC 480”).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 9 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company will proceed with a Business Combination if the Company has net tangible assets of at least $<span id="xdx_905_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment_iI_c20250930__srt--RangeAxis__srt--MinimumMember_zBq45DNgTWb7" title="Business combination, net tangible assets"><ix:nonFraction name="us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment" contextRef="AsOf2025-09-30_srt_MinimumMember" id="Fact000590" format="ixt:numdotdecimal" decimals="0" unitRef="USD">5,000,001</ix:nonFraction></span> upon such consummation
of a Business Combination and, if the Company seeks shareholder approval, a majority of the outstanding shares voted are voted in favor
of the Business Combination. If a shareholder vote is not required and the Company does not decide to hold a shareholder vote for business
or other legal reasons, the Company will, pursuant to its Amended and Restated Memorandum and Articles of Association, offer such redemption
pursuant to the tender offer rules of the SEC, and file tender offer documents containing substantially the same information as would
be included in a proxy statement with the SEC prior to completing a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor and any of the Company’s officers or directors that may hold Founder Shares (as described in Note 5) (as defined the “initial
shareholders”) are identical to the ordinary shares included in the units being sold in this offering except that the founder shares
are subject to certain transfer restrictions, as described in more detail below: the sponsor, officers and directors have entered into
a letter agreement with us, pursuant to which they have agreed (i) to waive their redemption rights with respect to their founder shares,
private placement shares and public shares in connection with the completion of the initial business combination, (ii) to waive their
redemption rights with respect to any founder shares, private placement shares and public shares held by them in connection with a shareholder
vote to approve an amendment to the amended and restated memorandum and articles of association (A) to modify the substance or timing
of obligation to provide for the redemption of public shares in connection with an initial business combination or to redeem <span id="xdx_90C_ecustom--PercentOfObligationToRedeemPublicShares_iI_pid_dp_uPure_c20250930_zbNgYjfLoYwe" title="Percent of obligation to redeem public shares"><ix:nonFraction name="DYCQ:PercentOfObligationToRedeemPublicShares" contextRef="AsOf2025-09-30" id="Fact000592" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of
public shares if the Company have not consummated the initial business combination within the timeframe set forth therein or (B) with
respect to any other provision relating to shareholders’ rights or pre-initial business combination activity and (iii) to waive
their rights to liquidating distributions from the Trust Account with respect to their founder shares and private placement shares if
the Company fail to complete the initial business combination within nine months from the closing of this offering (or up to 21 months
from the closing of this offering if the Company extend the period of time to consummate a business combination, as described in more
detail in this prospectus) (although they will be entitled to liquidating distributions from the Trust Account with respect to any public
shares they hold if the Company fail to complete the initial business combination within the prescribed time frame).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company’s amended and restated memorandum and articles of association provided that the Company complete its initial business combination
within nine months (or 12 months if the Company executes a definitive agreement for an initial business combination) from the closing
of the IPO, the Company may extend the period of time to consummate a Business Combination up to twelve times, each by an additional
one month each time (for a total of 24 months to complete a Business Combination (the “Combination Period”), including automatic
extension period). In order to extend the time available for the Company to consummate a Business Combination, the Sponsor or its affiliate
or designees must deposit into the Trust Account $<span id="xdx_90F_eus-gaap--Deposits_iI_c20250930_zYIQamHgF4E9" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-09-30" id="Fact000594" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,000</ix:nonFraction></span> (approximately $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250930__srt--StatementScenarioAxis__custom--EachMonthlyExtensionMember_zj4aZuu3Mwr2" title="Shares issued, price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-09-30_custom_EachMonthlyExtensionMember" id="Fact000596" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.03</ix:nonFraction></span> per public share), on or prior to the date of the applicable
deadline, for each month extension. Any funds which may be provided to extend the time frame will be in the form of a loan to the Company
from the Sponsor. The terms of any such loan have not been definitely negotiated, provided, however, any loan will be interest free and
will be repayable only if the Company completes a Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company entered into a definitive business combination agreement on October 22, 2024, which is within nine months after the closing of
the IPO, as such the Company had an automatic three-month extension to the original nine months from the closing of the IPO to consummate
its initial business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 10 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
January 20, 2025, the Company entered into certain Subscription Agreement (the “Subscription Agreement”) with Maius, Pubco
and certain investor (the “Investor”), pursuant to which, among other things, the Investor agreed to subscribe for and purchase,
and Pubco agreed to issue and sell to the Investor, <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250120__20250120__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zIPRrLYwdiLg" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-01-202025-01-20_us-gaap_InvestorMember" id="Fact000598" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">30,000</ix:nonFraction></span> ordinary shares of Pubco, par value $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250120__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zwdmlTPF9F2k" title="Ordinary shares par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-01-20_us-gaap_InvestorMember" id="Fact000600" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, at a purchase price
equal to $<span id="xdx_900_eus-gaap--SharePrice_iI_c20250120__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_z1xFNgGRA6g4" title="Purchase price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-01-20_us-gaap_PrivatePlacementMember" id="Fact000602" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share in a private placement (the “Private Placement”) in connection with a financing effort related
to the transactions contemplated by the Business Combination Agreement. The purchase price was paid into Escrow in accordance with the
Business Combination Agreement. The closing of the Private Placement is conditioned upon, among other things, the completed or concurrent
consummation of the Transactions set forth in the Business Combination Agreement. In the event, the Business Combination Agreement is
terminated, the purchase price share be returned to the investor. During the nine months ended September 30, 2025, a total of $<span id="xdx_908_eus-gaap--OtherNotesPayableCurrent_iI_c20250930_zitAQ0neR2t4" title="Other payables"><ix:nonFraction name="us-gaap:OtherNotesPayableCurrent" contextRef="AsOf2025-09-30" id="Fact000604" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span>
in expenses and extension loan was paid from Escrow on behalf of the Company and is presented as other payable in the unaudited balance
sheet.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 22, 2025, the Company deposited $<span id="xdx_90B_eus-gaap--Deposits_iI_c20250222_zkjQUvRxgDB5" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-02-22" id="Fact000606" format="ixt:numdotdecimal" decimals="0" unitRef="USD">207,000</ix:nonFraction></span> into the Trust Account in order to extend the amount of available time to complete
a business combination until March 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 20, 2025, the Company held an extraordinary general meeting of shareholders and passed a special resolution to amend our amended
and restated memorandum and articles of association then effective, giving the Company the right to extend the date by which it has to
complete a business combination up to May 23, 2026.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 24, 2025, in connection with the stockholders vote at the Extraordinary General Meeting, <span id="xdx_906_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250324__20250324_zXQbhQ3Fz4ej" title="Redeemed shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2025-03-242025-03-24" id="Fact000608" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,868,367</ix:nonFraction></span> shares were redeemed by certain
shareholders at a price of approximately $<span id="xdx_906_eus-gaap--SaleOfStockPricePerShare_iI_c20250324_zPCKTBObMxIl" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-03-24" id="Fact000610" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.61</ix:nonFraction></span> per share, including interest generated and extension payments deposited in the Trust
Account, in an aggregate amount of $<span id="xdx_90B_eus-gaap--PaymentsForDeposits_c20250324__20250324_zzi43uM4QQ3f" title="Payments for deposits"><ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2025-03-242025-03-24" id="Fact000612" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,821,345</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
March 25, 2025, the Company deposited $<span id="xdx_90B_eus-gaap--Deposits_iI_c20250325_zA3VYsMhClEl" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-03-25" id="Fact000614" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,949</ix:nonFraction></span> into the Trust Account in order to extend the amount of available time to complete a business
combination until April 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2025, the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) and
obtain approval by special resolution, the Company’s amended and restated memorandum and articles of association (the “Amended
and Restated Memorandum and Articles of Association”) to extend the maximum period the Company may extend the period of time to
consummate a Business Combination, on a month-to-month basis and subject to the sponsor depositing additional funds for each one-month
extension into the trust account, from up to fifteen times (i.e., until May 23, 2026) to up to eighteen times (i.e., until August 23,
2026), by amending the Amended and Restated Memorandum and Articles of Association (the “ Extension Amendment Proposal”)</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2025, the Trust Amendment Proposal was approved to amend by ordinary resolution, the Investment Management Trust Agreement,
dated February 20, 2024, by and between the Company and Continental Stock Transfer & Trust Company, as trustee, to reflect the Extension
Amendment Proposal.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
April 23, 2025, in connection with the vote to approve the Extension Amendment Proposal and the Trust Amendment Proposal, holders of
<span id="xdx_903_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250423__20250423_zcHNNzvJ6T13" title="Redeemed shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2025-04-232025-04-23" id="Fact000616" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">326,904</ix:nonFraction></span> ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately
$<span id="xdx_907_eus-gaap--SaleOfStockPricePerShare_iI_c20250423_z4rTgvuiZU87" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-04-23" id="Fact000618" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.68</ix:nonFraction></span> per share, for an aggregate redemption amount of approximately $<span id="xdx_904_eus-gaap--PaymentsForDeposits_c20250423__20250423_zIhkqhQgygWe" title="Payments for deposits"><ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2025-04-232025-04-23" id="Fact000620" format="ixt:numdotdecimal" decimals="0" unitRef="USD">3,492,160</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 11 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_902_eus-gaap--CommonStockVotingRights_c20250521__20250521__us-gaap--TypeOfArrangementAxis__custom--VotingAgreementsMember_zHjH0afMb3Q7" title="Redemption shares description"><ix:nonNumeric contextRef="From2025-05-212025-05-21_custom_VotingAgreementsMember" id="Fact000622" name="us-gaap:CommonStockVotingRights">On May 21, 2025, the Company and Maius entered into Voting Agreements with certain shareholders of the Company. Pursuant to the Voting
Agreements, in the event a shareholder redeems 75% of the ordinary shares of the Company that such shareholder holds as of the dates of
the Voting Agreements (the “Redemption Shares”) and foregoes the exercise of their redemption rights in connection with the
remaining 25% of the ordinary shares of the Company that such shareholder holds as of the dates of the Voting Agreements (the “Non-redeemed
Shares”), vote in favor of the approval of the Extension Fee Reduction, for any proposal to adjourn or postpone the applicable general
meeting to a later date proposed by the Company for purposes of obtaining the approval of the Extension Fee Reduction and against any
action, proposal, transaction or agreement that would reasonably be expected to result in a breach in any respect of any covenant, representation
or warranty or any other obligation or agreement of the Investors in this Agreement.</ix:nonNumeric></span> The Company agrees to issue to such shareholder two
(2) additional rights of the Company (the “Additional SPAC Rights”) for each Non-redeemed Share for no additional consideration.
The Additional SPAC Rights was determined using the quoted market price of the rights which agreed to issue to the non-redeeming third
parties and determined the rights had a value of $<span id="xdx_902_ecustom--NonredemptionAgreementExpense_c20250101__20250930_zrqvnj9Ok3vj" title="Non-redemption agreement expense"><ix:nonFraction name="DYCQ:NonredemptionAgreementExpense" contextRef="From2025-01-01to2025-09-30" id="Fact000624" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,022</ix:nonFraction></span>. This amount is presented as non-redemption agreement expense in the statements
of operations.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2025, the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) to
approve the Extension Fee Reduction Proposal to $<span id="xdx_908_ecustom--ExtensionFee_c20250523__20250523_zmH053S6IW27" title="Extension fee reduction proposal"><ix:nonFraction name="DYCQ:ExtensionFee" contextRef="From2025-05-232025-05-23" id="Fact000626" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span> for all outstanding Public Shares (the “Amended Monthly Extension Fee”).
The Amended Monthly Extension Fee became operative for the Monthly Extension Fee beginning on May 23, 2025, and the 23rd of each succeeding
month until the earlier of the closing of an initial business combination or August 23, 2026.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2025, the Company amend the amended and restated memorandum and articles of association (the “Amended and Restated Memorandum
and Articles of Association”) to reflect the Extension Fee Reduction Proposal, by amending the Amended and Restated Memorandum
and Articles of Association to delete the existing Article 37.8 thereof and replacing it with the new Article 37.8 in the form set forth
in Annex B of the proxy statement.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 23, 2025, in connection with the vote to approve the Extension Amendment Proposal and the Trust Amendment Proposal, holders of <span id="xdx_90C_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250523__20250523_zoO1mifEwSmi" title="Redeemed shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2025-05-232025-05-23" id="Fact000628" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,872,314</ix:nonFraction></span>
ordinary shares of the Company properly exercised their right to redeem their shares for cash at a redemption price of approximately
$<span id="xdx_900_eus-gaap--SaleOfStockPricePerShare_iI_c20250523_zWJMcpqjKB3k" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-05-23" id="Fact000630" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.79</ix:nonFraction></span> per share, for an aggregate redemption amount of approximately $<span id="xdx_90D_eus-gaap--PaymentsForDeposits_c20250523__20250523_zbVsRFvrSnX7" title="Payments for deposits"><ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2025-05-232025-05-23" id="Fact000632" format="ixt:numdotdecimal" decimals="0" unitRef="USD">41,776,748</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
June 23, 2025, the Company deposited $<span id="xdx_90C_eus-gaap--Deposits_iI_c20250623_zejL3IJtvPXj" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-06-23" id="Fact000634" format="ixt:numdotdecimal" decimals="0" unitRef="USD">141,142</ix:nonFraction></span> and $<span id="xdx_902_eus-gaap--AssetsHeldInTrust_iI_c20250623_zMFBJZsUNTF7" title="Deposits trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrust" contextRef="AsOf2025-06-23" id="Fact000636" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span> into the Trust Account in order to extend the amount of available time to complete
a business combination until June 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
July 30, 2025, the Company deposited $<span id="xdx_901_eus-gaap--Deposits_iI_c20250730_zEvlyhjzSzf7" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-07-30" id="Fact000638" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span> into the Trust Account in order to extend the amount of available time to complete a business
combination until July 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2025, the Company deposited $<span id="xdx_908_eus-gaap--Deposits_iI_c20250923_zjboE1SPZR27" title="Deposits"><ix:nonFraction name="us-gaap:Deposits" contextRef="AsOf2025-09-23" id="Fact000640" format="ixt:numdotdecimal" decimals="0" unitRef="USD">60,000</ix:nonFraction></span> into the Trust Account in order to extend the amount of available time to complete
a business combination until August 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From
February 2025 to September 2025, the Company using the funds held outside the Trust Account, the Company made six times deposit for an
aggregate of $<span id="xdx_90B_eus-gaap--TimeDeposits_iI_c20250930_z7Z8rNOEQF94" title="Time deposit"><ix:nonFraction name="us-gaap:TimeDeposits" contextRef="AsOf2025-09-30" id="Fact000642" format="ixt:numdotdecimal" decimals="0" unitRef="USD">679,091</ix:nonFraction></span>, to the Trust Account and extended the Combination Period from February 24, 2025 to August 23, 2025.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2025, the Company amend the amended and restated memorandum and articles of association (the “Amended and Restated Memorandum
and Articles of Association”) to extend the maximum period the Company may extend the period of time to consummate a Business Combination,
on a month-to-month basis and subject to, unless having been waived, the Sponsor depositing additional funds for each one-month extension
into the Trust Account, from up to eighteen times (i.e., until August 23, 2026) to up to twenty-four times (i.e., until February 23,
2027) (the “Extension Amendment”), by amending the Amended and Restated Memorandum and Articles of Association in the form
set forth in Annex A of the accompanying proxy statement.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 21, 2025, an ordinary resolution approved at the Extraordinary General Meeting, the monthly fee (the “Monthly Extension
Fee”) payable by the Sponsor and/or its designee into the Trust Account to extend the date by which the Company must consummate
its initial business combination (the “Extension Fee Waiver”). The Extension Fee Waiver will become operative for the Monthly
Extension Fee beginning on August 23, 2025, and the 23rd of each succeeding month until the earlier of the closing of an initial business
combination or February 23, 2027.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 23, 2025, in connection with the vote to approve the Extension Amendment Proposal, holders of <span id="xdx_909_eus-gaap--StockRedeemedOrCalledDuringPeriodShares_c20250923__20250923_zsJgXNsXNmbk" title="Redeemed shares"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodShares" contextRef="From2025-09-232025-09-23" id="Fact000644" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">689,033</ix:nonFraction></span> ordinary shares of the
Company properly exercised their right to redeem their shares for cash at a redemption price of approximately $<span id="xdx_90C_eus-gaap--SaleOfStockPricePerShare_iI_c20250923_zNST1qnCAkL8" title="Price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-09-23" id="Fact000646" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">11.15</ix:nonFraction></span> per share, for an
aggregate redemption amount of approximately $<span id="xdx_904_eus-gaap--PaymentsForDeposits_c20250923__20250923_zUJ4q4VVq5V2" title="Payments for deposits"><ix:nonFraction name="us-gaap:PaymentsForDeposits" contextRef="From2025-09-232025-09-23" id="Fact000648" format="ixt:numdotdecimal" decimals="0" unitRef="USD">7,669,294</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 29, 2025, the Company entered into certain Subscription Agreement (the “Subscription Agreement”) with Maius, Pubco
and certain investor (the “Investor”), pursuant to which, among other things, the Investor agreed to subscribe for and purchase,
and Pubco agreed to issue and sell to the Investor, <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20250929__20250929__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zn5bBHfpCMs4" title="Number of shares sold"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-09-292025-09-29_us-gaap_InvestorMember" id="Fact000650" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,000</ix:nonFraction></span> ordinary shares of Pubco, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20250929__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__us-gaap--InvestorMember_zXZWgvfyTLLi" title="Ordinary shares par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-09-29_us-gaap_InvestorMember" id="Fact000652" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> per share, at a purchase price
equal to $<span id="xdx_90C_eus-gaap--SharePrice_iI_c20250929__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zBZ0VNKZ0CM7" title="Purchase price per share"><ix:nonFraction name="us-gaap:SharePrice" contextRef="AsOf2025-09-29_us-gaap_PrivatePlacementMember" id="Fact000654" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per share in a private placement (the “Private Placement”) in connection with a financing effort related
to the transactions contemplated by the Business Combination Agreement. The transaction would be occurred at the closing of the initial
business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Business
combination agreement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
September 3, 2024, the Company entered into a non-binding letter of intent (the “LOI”) with Shanghai Maius Pharmaceutical
Technology Co., LTD (“Shanghai Maius”). Under the terms of the LOI, the Company would acquire <span id="xdx_900_ecustom--PercentOfObligationToRedeemPublicShares_iI_pid_dp_uPure_c20240903_zRiI6gDQn725" title="Percent of obligation to redeem public shares"><ix:nonFraction name="DYCQ:PercentOfObligationToRedeemPublicShares" contextRef="AsOf2024-09-03" id="Fact000656" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Shanghai Maius’s
outstanding equity and equity equivalents or all of its business.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, the Company, Maius Pharmaceutical Co., Ltd., an exempted company limited by shares incorporated under the laws of the
Cayman Islands (“Maius”)”, Maius Pharmaceutical Group Co., Ltd., an exempted company limited by shares incorporated
under the laws of the Cayman Islands (“Pubco”) incorporated for the purpose of serving as the public listed company whose
shares shall be traded on The Nasdaq Stock Market LLC (“Nasdaq”), Chelsea Merger Sub 1 Limited, a Cayman Islands exempted
company (“Merger Sub 1”), Chelsea Merger Sub 2 Limited, a Cayman Islands exempted company (“Merger Sub 2”), and
XXW Investment Limited, a limited liability company incorporated under the laws of British Virgin Islands as Maius’ representative
(the “Shareholders’ Representative”), entered into a business combination agreement (the “Business Combination
Agreement”).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 12 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to, and in accordance with the terms and conditions of the Business Combination Agreement, (i) on the date on which the closing actually
occurs (the “Closing Date”), Merger Sub 1 shall be merged with and into the Company (the “SPAC Merger”), with
the Company continuing as the surviving company of the merger as a wholly-owned subsidiary of the Pubco (the “SPAC Merger Surviving
Corporation”) and the separate existence of the Merger Sub 1 shall cease, and (ii) on the Closing Date and immediately following
the SPAC Merger, Merger Sub 2 shall be merged with and into Maius (the “Acquisition Merger”, together with the SPAC Merger,
the “Mergers”), with Maius continuing as the surviving company of the Acquisition Merger as a wholly-owned subsidiary of
the Pubco (the “Surviving Corporation”) and the separate existence of the Merger Sub 2 shall cease. The Mergers and each
of the other transactions contemplated by the Business Combination Agreement and other Ancillary Documents are collectively referred
to as the “Transactions.” Under the Agreement, the aggregate consideration is Two Hundred and Fifty Million Dollars ($<span id="xdx_906_eus-gaap--PaymentsForMergerRelatedCosts_c20250101__20250930_zzbwZMBkw8f9" title="Payment of merger consideration"><ix:nonFraction name="us-gaap:PaymentsForMergerRelatedCosts" contextRef="From2025-01-01to2025-09-30" id="Fact000658" format="ixt:numdotdecimal" decimals="0" unitRef="USD">250,000,000</ix:nonFraction></span>)
(the “Closing Date Merger Consideration” or “Consideration”), which will be paid entirely in newly issued ordinary
shares of Pubco.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidation</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except
for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter, redeem 100% of
the outstanding Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account,
including interest earned (net of taxes payable), which redemption will completely extinguish public shareholders’ rights as shareholders
(including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining shareholders and the Company’s board of directors,
proceed to commence a voluntary liquidation and thereby a formal dissolution of the Company, subject in each case to its obligations
to provide for claims of creditors and the requirements of applicable law. The underwriters have agreed to waive its rights to the deferred
underwriting commission held in the Trust Account in the event the Company does not complete a Business Combination within the Combination
Period and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the
redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the assets remaining available
for distribution will be less than $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250930_z9Jxl6OSUFPi" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-09-30" id="Fact000660" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span>.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Sponsor has agreed that it will be liable to the Company, if and to the extent any claims by a vendor for services rendered or products
sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce
the amounts in the Trust Account to below $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20250930_zch39uTcgcE6" title="Shares issued price per share"><ix:nonFraction name="us-gaap:SharesIssuedPricePerShare" contextRef="AsOf2025-09-30" id="Fact000662" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.05</ix:nonFraction></span> per share (whether or not the underwriters’ over-allotment option is exercised
in full), except as to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account and
except as to any claims under the Company’s indemnity of the underwriters of the “Initial Public Offering” against
certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). In the event
that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any
liability for such third party claims. The Company will seek to reduce the possibility that the Sponsor will have to indemnify the Trust
Account due to claims of creditors by endeavouring to have all vendors, service providers, prospective target businesses or other entities
with which the Company does business, execute agreements with the Company waiving any right, title, interest or claim of any kind in
or to monies held in the Trust Account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern Consideration</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company expects to incur significant costs in pursuit of its financing and acquisition plans. In connection with the Company’s
assessment of going concern considerations in accordance with Accounting Standards Update (“ASU”) 2014-15, “Disclosures
of Uncertainties about an Entity’s Ability to Continue as a Going Concern,” management has determined that if the Company
is unsuccessful in consummating an Initial Business Combination within the prescribed period of time (subject to the Amended Extension
Payment is made as required for each monthly extension), the requirement that the Company cease all operations, redeem the Public Shares
and thereafter liquidate and dissolve raises substantial doubt about the Company’s ability to continue as a going concern within
one year after the date that the financial statements are issued. The unaudited financial statements do not include any adjustments that
might result from the outcome of this uncertainty. The accompanying unaudited financial statements have been prepared in conformity with
generally accepted accounting principles in the United States of America (“GAAP”), which contemplate continuation of the
Company as a going concern. The Company intends to continue to seek to complete a Business Combination before the mandatory liquidation
date. However, there can be no assurance that we will be able to consummate any business combination within the prescribed period of
time.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 13 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000664" name="us-gaap:SignificantAccountingPoliciesTextBlock"><p id="xdx_80D_eus-gaap--SignificantAccountingPoliciesTextBlock_zrCwByK19Pt7" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
2 – <span id="xdx_825_zN1ZwRdWnDk2">SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000666" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock"><p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zk7gx0u9gU64" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_863_zExrwdYxQwif">Basis of presentation</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles in the United
States of America (“U.S. GAAP”) for interim financial statements and Article 8 of Regulation S-X. They do not include all
of the information and notes required by U.S. GAAP for complete financial statements. The unaudited financial statements should be read
in conjunction with the Company’s financial statements and notes thereto for the year ended December 31, 2024 included in the Company’s
Annual Report on Form 10-K. In the opinion of management, all adjustments (consisting of normal recurring adjustments) have been made
that are necessary to present fairly the financial position, and the results of its operations and its cash flows. Operating results
as presented are not necessarily indicative of the results to be expected for a full year.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000668" name="DYCQ:EmergingGrowthCompanyPolicyTextBlock"><p id="xdx_847_ecustom--EmergingGrowthCompanyPolicyTextBlock_zkp5ePLGyTtl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86C_zIEnNqnwb8Q5">Emerging growth company</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart Our
Business Startups Act of 2012 (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements
that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required
to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding
executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory
vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Further,
Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting
standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do
not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting
standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements
that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of
such extended transition period which means that when a standard is issued or revised and it has different application dates for public
or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies
adopt the new or revised standard. This may make comparison of the Company’s unaudited financial statements with another public
company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition
period difficult or impossible because of the potential differences in accounting standards used.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000670" name="us-gaap:UseOfEstimates"><p id="xdx_840_eus-gaap--UseOfEstimates_zvfZhF4vUGS9" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zZrgjxZkjTW4">Use of estimates</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of unaudited financial statements in conformity with GAAP requires management to make estimates and assumptions that affect
the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited financial
statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making
estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of
a condition, situation or set of circumstances that existed at the date of the unaudited financial statements, which management considered
in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results
could differ significantly from those estimates.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 14 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000672" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock"><p id="xdx_845_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zhLhGv6QwmG8" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zn6w6soYiul9">Cash and cash equivalents</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
As of September 30, 2025 and December 31, 2024, the cash balance was $<span id="xdx_90D_eus-gaap--Cash_iI_dxL_c20250930_zrvqNObvKByb" title="Cash::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0674">0</span></span> and $<span id="xdx_901_eus-gaap--Cash_iI_c20241231_zsej8uRflc2e" title="Cash"><ix:nonFraction name="us-gaap:Cash" contextRef="AsOf2024-12-31" id="Fact000676" format="ixt:numdotdecimal" decimals="0" unitRef="USD">152,021</ix:nonFraction></span>, respectively. The Company did not have any cash
equivalents as of September 30, 2025 and December 31, 2024.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000678" name="DYCQ:CashAndInvestmentHeldInTrustAaccountPolicyTextBlock"><p id="xdx_84B_ecustom--CashAndInvestmentHeldInTrustAaccountPolicyTextBlock_zj2aenbVjdy1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_864_zjmvkaolHvnd">Cash and Investment held in trust account</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025 and December 31, 2024, substantially all of the assets held in the Trust Account were held in money market funds
investing in U.S. Treasuries. Investments in money market funds are presented on the unaudited balance sheets at fair value at the end
of each reporting period. Earnings on investments held in the Trust Account are included in dividend income earned on investments held
in the Trust Account in the accompanying unaudited statement of operations. The estimated fair values of investments held in Trust Account
are determined using available market information. As of September 30, 2025 and December 31, 2024, the estimated fair values of investments
held in Trust Account were $<span id="xdx_902_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20250930_zqdCXUwTdLf9" title="Investments held in trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2025-09-30" id="Fact000680" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,598,106</ix:nonFraction></span> and $<span id="xdx_909_eus-gaap--AssetsHeldInTrustNoncurrent_iI_c20241231_z8Q8O5Goxu29" title="Investments held in trust account"><ix:nonFraction name="us-gaap:AssetsHeldInTrustNoncurrent" contextRef="AsOf2024-12-31" id="Fact000682" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,345,071</ix:nonFraction></span>, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000684" name="DYCQ:OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock"><p id="xdx_84E_ecustom--OrdinarySharesSubjectToPossibleRedemptionPolicyTextBlock_zID2ZmjwZrUf" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86A_zJYkYtqfbjH">Ordinary shares subject to possible redemption</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company accounts for its ordinary shares subject to possible redemption in accordance with the guidance in ASC 480. Ordinary share subject
to mandatory redemption (if any) is classified as a liability instrument and is measured at fair value. Conditionally redeemable ordinary
shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption
upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other
times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights
that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, as
of September 30, 2025 and December 31, 2024, <span id="xdx_90A_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20250930_zuDcd0Tey7m2" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2025-09-30" id="Fact000686" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">143,382</ix:nonFraction></span> and <span id="xdx_900_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20241231_zCxlAt1kzMIl" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000688" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> ordinary shares subject to possible redemption are presented at redemption
value as temporary equity, outside of the shareholders’ deficit section of the Company’s unaudited balance sheets, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000690" name="us-gaap:IncomeTaxPolicyTextBlock"><p id="xdx_84A_eus-gaap--IncomeTaxPolicyTextBlock_z9XkDLcXyhaa" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_867_zCAgcbU7Y1m">Income taxes</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income
taxes are determined in accordance with the provisions of ASC Topic 740, “Income Taxes” (“ASC 740”). Under this
method, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the unaudited
financial statements carrying amounts of existing assets and liabilities and their respective tax basis. Deferred tax assets and liabilities
are measured using enacted income tax rates expected to apply to taxable income in the years in which those temporary differences are
expected to be recovered or settled. Any effect on deferred tax assets and liabilities of a change in tax rates is recognized in income
in the period that includes the enactment date.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
740 prescribes a comprehensive model for how companies should recognize, measure, present, and disclose in their unaudited financial
statements uncertain tax positions taken or expected to be taken on a tax return. Under ASC 740, tax positions must initially be recognized
in the unaudited financial statements when it is more likely than not the position will be sustained upon examination by the tax authorities.
The Company’s management determined that the Cayman Islands is the Company’s major tax jurisdiction. The Company recognizes
accrued interest and penalties related to unrecognized tax benefits, if any, as income tax expense. There were no unrecognized tax benefits
and no amounts accrued for interest and penalties as of September 30, 2025 and December 31, 2024. The Company is currently not aware
of any issues under review that could result in significant payments, accruals or material deviation from its position.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company may be subject to potential examination by foreign taxing authorities in the area of income taxes. These potential examinations
may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with
foreign tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change
over the next twelve months.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently
not subject to income taxes or income tax filing requirements in the Cayman Islands or the United States. As such, the Company’s
tax provision was zero for the periods presented.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 15 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000692" name="us-gaap:EarningsPerSharePolicyTextBlock"><p id="xdx_844_eus-gaap--EarningsPerSharePolicyTextBlock_zZlA8CFo8RW3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_zzPcFnu4mZ4k">Net income per share</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company calculates net income (loss) per share in accordance with ASC Topic 260, “Earnings per Share.” Net income (loss)
per ordinary share is computed by dividing net income (loss) by the weighted average number of ordinary shares outstanding for the period.
Income and losses are shared pro rata between the redeemable shares and non-redeemable shares. Remeasurement associated with the redeemable
shares of ordinary shares is excluded from earnings per share as the redemption value approximates fair value. The Company did not have
any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in
the earnings of the Company. As a result, diluted income (loss) per ordinary share is the same as basic income (loss) per ordinary share
for the periods presented. The rights cannot be converted to ordinary shares prior to an initial Business Combination; therefore, they
have been classified as anti-dilutive.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000694" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"><p id="xdx_89F_eus-gaap--ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_zST0a9mzbxE1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
net income (loss) per share presented in the statements of operations is based on the following:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zr7K9qlOf5fl" style="display: none">SCHEDULE
OF NET INCOME PER SHARE</span></span></span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_496_20250101__20250930_zus9q4aJOfVd" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended<br/> September 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_496_20240101__20240930_zDFK4rfFiCT4" style="border-bottom: Black 1pt solid; text-align: center">For the nine months ended <br/>September 30, 2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr id="xdx_400_eus-gaap--NetIncomeLoss_zwOmH8kwcBs4" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 68%; text-align: left; padding-bottom: 2.5pt">Net income</td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-01to2025-09-30" id="Fact000696" format="ixt:numdotdecimal" decimals="0" unitRef="USD">444,595</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-09-30" id="Fact000697" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,633,003</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_49B_20250701__20250930_zhKg5HDkxLpe" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended<br/> September 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_497_20240701__20240930_zanJ9UvliZPl" style="border-bottom: Black 1pt solid; text-align: center">For the three months ended <br/>September 30, 2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr id="xdx_40F_eus-gaap--NetIncomeLoss_zAcjCKJ7VTa6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 68%; text-align: left; padding-bottom: 2.5pt">Net income (loss)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30" id="Fact000699" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">242,147</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 12%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30" id="Fact000700" format="ixt:numdotdecimal" decimals="0" unitRef="USD">760,262</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="display: none; vertical-align: bottom">
<td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_498_20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zLBgPdscwaQa" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_498_20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zXVeItURjxFf" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_49B_20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zSlkJJ3WHyk2" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_493_20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zIxGAuGERiLi" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="6" style="text-align: center">For the nine months ended</td><td> </td><td> </td>
<td colspan="6" style="text-align: center">For the nine months ended</td><td> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">September 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Redeemable <br/> Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-Redeemable <br/>Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Redeemable.<br/> Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-Redeemable <br/>Ordinary Share</td><td style="padding-bottom: 1pt"> </td></tr>
<tr id="xdx_409_eus-gaap--EarningsPerShareBasicAbstract_iB_zhFTQLAfWpZ2" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Basic and diluted net income per ordinary share:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Numerators:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLoss_zeOCRdgrqa72" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 44%; text-align: left; padding-bottom: 2.5pt">Allocation of net income</td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000707" format="ixt:numdotdecimal" decimals="0" unitRef="USD">293,738</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000708" format="ixt:numdotdecimal" decimals="0" unitRef="USD">150,857</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000709" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,200,429</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000710" format="ixt:numdotdecimal" decimals="0" unitRef="USD">432,574</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Denominators:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 1pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zxbeO02xLoq5" title="Weighted-average shares outstanding, basic"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zhYwMVnrBLLg" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000712" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000714" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">4,016,929</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90C_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_ztlhHOg3puD3" title="Weighted-average shares outstanding, basic"><span id="xdx_906_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zzR7mMFzS6Wk" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000716" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000718" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zDMHjxCguc3e" title="Weighted-average shares outstanding, basic"><span id="xdx_901_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zwXrbIWgSFQ3" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000720" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000722" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,540,146</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zOgntxfzBrQf" title="Weighted-average shares outstanding, basic"><span id="xdx_903_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_z08VYaEQUzF1" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000724" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000726" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,996,387</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per ordinary share</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zXKMfABX3oUh" title="Basic net income per ordinary share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zJ0tU7gf6Ewb" title="Diluted net income per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000728" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-01-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000730" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_900_eus-gaap--EarningsPerShareBasic_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_z5OM7kfLUqL6" title="Basic net income per ordinary share"><span id="xdx_904_eus-gaap--EarningsPerShareDiluted_pid_c20250101__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zW5rghojIjr8" title="Diluted net income per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000732" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-01-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000734" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.07</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zimHAGrNOCIc" title="Basic net income per ordinary share"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zw3sA0DpcwI1" title="Diluted net income per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000736" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000738" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.22</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90C_eus-gaap--EarningsPerShareBasic_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zHW767XU4xVg" title="Basic net income per ordinary share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20240101__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zPHnzG0z6J21" title="Diluted net income per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000740" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-01-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000742" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.22</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 95%">
<tr style="display: none; vertical-align: bottom">
<td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_497_20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zPBhvXyy999j" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_49F_20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_z1JuX59GNg11" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_498_20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zDiApvYlGu66" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td><td style="text-align: center; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_495_20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zi1jCOs0JE14" style="border-bottom: Black 1pt solid; text-align: center"> </td><td style="text-align: center; padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td> </td>
<td colspan="6" style="text-align: center">For the three months ended</td><td> </td><td> </td>
<td colspan="6" style="text-align: center">For the three months ended</td><td> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">September 30, 2025</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="6" style="border-bottom: Black 1pt solid; text-align: center">September 30, 2024</td><td style="padding-bottom: 1pt"> </td></tr>
<tr style="vertical-align: bottom">
<td> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Redeemable <br/> Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-Redeemable <br/>Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Redeemable.<br/> Ordinary Share</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td>
<td colspan="2" style="border-bottom: Black 1pt solid; text-align: center">Non-Redeemable <br/>Ordinary Share</td><td style="padding-bottom: 1pt"> </td></tr>
<tr id="xdx_40E_eus-gaap--EarningsPerShareBasicAbstract_iB_zaZtC4t7pO39" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="text-align: left">Basic and diluted net income per ordinary share:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Numerators:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40D_eus-gaap--NetIncomeLoss_zrVVw4fd5pth" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="width: 44%; text-align: left; padding-bottom: 1pt">Allocation of net income (loss)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000749" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">66,434</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000750" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">175,713</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left">)</td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000751" format="ixt:numdotdecimal" decimals="0" unitRef="USD">585,274</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1pt solid; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000752" format="ixt:numdotdecimal" decimals="0" unitRef="USD">174,988</ix:nonFraction></td><td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td>Denominators:</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="padding-bottom: 1pt">Weighted-average shares outstanding</td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90D_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zOqSi6fdBYj3" title="Weighted-average shares outstanding, basic"><span id="xdx_90E_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zP4k2YxLmdwi" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000754" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000756" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">779,989</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zySc0LX4k408" title="Weighted-average shares outstanding, basic"><span id="xdx_900_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_z3zFYyyI9vx4" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000758" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000760" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_90B_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zvJTPkNdcXi9" title="Weighted-average shares outstanding, basic"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zqq9XeDCibr6" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000762" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000764" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td><td style="padding-bottom: 1pt"> </td>
<td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_907_eus-gaap--WeightedAverageNumberOfSharesOutstandingBasic_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zXIRwkg4m2Ff" title="Weighted-average shares outstanding, basic"><span id="xdx_904_eus-gaap--WeightedAverageNumberOfDilutedSharesOutstanding_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zyoXrO7vxF47" title="Weighted-average shares outstanding, diluted"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" contextRef="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000766" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" contextRef="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000768" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr>
<tr style="vertical-align: bottom; background-color: White">
<td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per ordinary share</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90E_eus-gaap--EarningsPerShareBasic_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zdcjJHai0m2a" title="Basic net income (loss) per ordinary share"><span id="xdx_908_eus-gaap--EarningsPerShareDiluted_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zbMUmFOJ6xne" title="Diluted net income (loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000770" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-07-012025-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000772" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90D_eus-gaap--EarningsPerShareBasic_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zDc4whaSgyAl" title="Basic net income (loss) per ordinary share"><span id="xdx_901_eus-gaap--EarningsPerShareDiluted_pid_c20250701__20250930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zEmZgxKc2JEb" title="Diluted net income (loss) per share">(<ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000774" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2025-07-012025-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000776" format="ixt:numdotdecimal" decimals="INF" sign="-" unitRef="USDPShares">0.09</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_90F_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zZXZH0t7SRvg" title="Basic net income (loss) per ordinary share"><span id="xdx_90B_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--RedeemableOrdinaryStockMember_zb7q7GI56j07" title="Diluted net income (loss) per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000778" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30_custom_RedeemableOrdinaryStockMember" id="Fact000780" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_901_eus-gaap--EarningsPerShareBasic_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_zdch0VVEFldj" title="Basic net income (loss) per ordinary share"><span id="xdx_90C_eus-gaap--EarningsPerShareDiluted_pid_c20240701__20240930__us-gaap--StatementClassOfStockAxis__custom--NonredeemableOrdinaryStockMember_z0vXtqLztIC1" title="Diluted net income (loss) per share"><ix:nonFraction name="us-gaap:EarningsPerShareBasic" contextRef="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000782" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares"><ix:nonFraction name="us-gaap:EarningsPerShareDiluted" contextRef="From2024-07-012024-09-30_custom_NonredeemableOrdinaryStockMember" id="Fact000784" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.08</ix:nonFraction></ix:nonFraction></span></span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
</ix:nonNumeric><p id="xdx_8A4_zmJbDjNr9N48" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 16 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000786" name="DYCQ:RelatedPartiesPolicyTextBlock"><p id="xdx_847_ecustom--RelatedPartiesPolicyTextBlock_z7mF1U13uql4" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_868_zgxQRPTXFcu7">Related parties</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties,
which can be a corporation or individual, are considered to be related if the Company has the ability, directly or indirectly, to control
the other party or exercise significant influence over the other party in making financial and operational decisions. Companies are also
considered to be related if they are subject to common control or common significant influence.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000788" name="us-gaap:FairValueOfFinancialInstrumentsPolicy"><p id="xdx_848_eus-gaap--FairValueOfFinancialInstrumentsPolicy_zRBz9ZDnpcea" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_86F_zXrn9nlNkbZ6">Fair value of financial instruments</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company’s assets and liabilities, which qualify as financial instruments under ASC Topic 820, “<i>Fair
Value Measurements and Disclosures</i>,” approximates the carrying amounts represented in the accompanying unaudited balance sheet,
primarily due to their short-term nature.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">“Fair
value” is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction
between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs
used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets
or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1 - Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in
which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing
basis.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2 - Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets
or liabilities and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3 - Unobservable inputs based on the Company’s assessment of the assumptions that market participants would use in pricing
the asset or liability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 17 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000790" name="us-gaap:ConcentrationRiskCreditRisk"><p id="xdx_843_eus-gaap--ConcentrationRiskCreditRisk_zgZ64yY0SKL3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_862_zJgPmzW02kOc">Concentration of credit risk</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial
instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution.
The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such
account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000792" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock"><p id="xdx_846_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_z1BghTuhkbtl" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_865_zAJkyieOKD4j">Recent accounting pronouncements</span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material
effect on the Company’s unaudited financial statements.</span></p>
<p id="xdx_8AD_zyeifUb5Mjw3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric></ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000794" name="DYCQ:InitialPublicOfferingTextBlock"><p id="xdx_801_ecustom--InitialPublicOfferingTextBlock_zNIfcajODBQe" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
3 – <span id="xdx_82A_zsesB6dAonj5">INITIAL PUBLIC OFFERING</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the Initial Public Offering, the Company sold <span id="xdx_90D_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zEc3gfVKCky2" title="Number of shares sold in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000796" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> Public Units, which includes <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zlHBqUaAREC2" title="Number of exercised shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000798" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">900,000</ix:nonFraction></span> Public Units upon the full exercise by
the underwriter of its over-allotment option, at a purchase price of $<span id="xdx_904_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zGDOGKvsTgdf" title="Sale of stock price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2024-02-23_us-gaap_IPOMember" id="Fact000800" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Public Unit. <span id="xdx_905_eus-gaap--SaleOfStockDescriptionOfTransaction_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zzes4zuaBa9e" title="Sale of stock, description of transaction"><ix:nonNumeric contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000802" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each Unit will consist of one ordinary share
and one Public Right. Each whole Public Right will entitle the holder to receive one-seventh (1/7) ordinary share upon consummation of
initial business combination.</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
of the <span id="xdx_903_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20240223__20240223__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zJbF2HeUYuuf" title="Number of shares sold in initial public offering"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2024-02-232024-02-23_us-gaap_IPOMember" id="Fact000804" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> public shares sold as part of the Public Units in the Initial Public Offering contain a redemption feature which allows
for the redemption of such public shares if there is a shareholder vote or tender offer in connection with the Business Combination and
in connection with certain amendments to the Company’s Amended and Restated Memorandum and Articles of Association, or in connection
with the Company’s liquidation. In accordance with the SEC and its staff’s guidance on redeemable equity instruments, which
has been codified in ASC 480-10-S99, redemption provisions not solely within the control of the Company require ordinary shares subject
to redemption to be classified outside of permanent equity.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company’s redeemable ordinary share is subject to SEC and its staff’s guidance on redeemable equity instruments, which has
been codified in ASC 480-10-S99. If it is probable that the equity instrument will become redeemable, the Company has the option to either
accrete changes in the redemption value over the period from the date of issuance (or from the date that it becomes probable that the
instrument will become redeemable, if later) to the earliest redemption date of the instrument or to recognize changes in the redemption
value immediately as they occur and adjust the carrying amount of the instrument to equal the redemption value at the end of each reporting
period. The Company has elected to recognize the changes immediately as they occur and adjusts the carrying value of redeemable shares
to equal the redemption value at the end of each reporting period. Increases or decreases in the carrying amount of redeemable shares
are affected by charges against additional paid in capital and accumulated deficit.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 18 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000806" name="DYCQ:PrivatePlacementTextBlock"><p id="xdx_801_ecustom--PrivatePlacementTextBlock_zI3282MejCc7" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
4 – <span id="xdx_820_z4JBIpEQsyb6">PRIVATE PLACEMENT</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of the Initial Public Offering, the Company consummated a private placement of <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20250101__20250930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zD9kiKqF0X5a" title="Sale of stock, number of shares issued in transaction"><ix:nonFraction name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" contextRef="From2025-01-012025-09-30_us-gaap_PrivatePlacementMember_custom_SponsorMember" id="Fact000808" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">234,500</ix:nonFraction></span> Private Placement Units, at a
price of $<span id="xdx_908_eus-gaap--SaleOfStockPricePerShare_iI_pid_c20250930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zOdP8DwO6SSc" title="Sale of stock, price per share"><ix:nonFraction name="us-gaap:SaleOfStockPricePerShare" contextRef="AsOf2025-09-30_us-gaap_PrivatePlacementMember_custom_SponsorMember" id="Fact000810" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per Private Placement Unit. <span id="xdx_90A_eus-gaap--SaleOfStockDescriptionOfTransaction_c20250101__20250930__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zRLCEdJwBgha" title="Units description"><ix:nonNumeric contextRef="From2025-01-012025-09-30_us-gaap_PrivatePlacementMember_custom_SponsorMember" id="Fact000812" name="us-gaap:SaleOfStockDescriptionOfTransaction">Each Private Placement Unit consists of one Private Placement Share and one right (“Private
Placement Right”). Each Private Placement Right will entitle the holder to receive one-seventh (1/7) ordinary share upon consummation
of the initial business combination.</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Private Placement Units are identical to the Public Units sold in the Initial Public Offering except for certain registration rights
and transfer restrictions</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000814" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock"><p id="xdx_803_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zxrCfvagCDv2" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
5 – <span id="xdx_826_z9s5tELSctV6">RELATED PARTY TRANSACTIONS</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.6pt; text-align: justify; text-indent: -28.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.6pt; text-align: justify; text-indent: -28.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Founder
Shares</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
July 2022, the Company issued an aggregate of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20220707__20220731_zTgsT4hIYx6b" title="Issuance of ordinary shares to founders, shares"><ix:nonFraction name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" contextRef="From2022-07-072022-07-31" id="Fact000816" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,725,000</ix:nonFraction></span> founder shares (“Founder Shares”) to the initial shareholders, so
that the Sponsor collectively owned <span id="xdx_906_ecustom--PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders_pid_dp_uPure_c20220707__20220731_zt4vQhEUfqm9" title="Sponsor owned, percentage"><ix:nonFraction name="DYCQ:PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders" contextRef="From2022-07-072022-07-31" id="Fact000818" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">20</ix:nonFraction></span>% of the Company’s issued and outstanding shares after the Initial Public Offering for an
aggregate purchase price of $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfCommonStock_c20220707__20220731_zikful6XGsLh" title="Aggregate purchase price"><ix:nonFraction name="us-gaap:ProceedsFromIssuanceOfCommonStock" contextRef="From2022-07-072022-07-31" id="Fact000820" format="ixt:numdotdecimal" decimals="0" unitRef="USD">25,000</ix:nonFraction></span> (see Note 7).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Due
to Related Party</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025 and December 31, 2024, the Company had a temporary advance and unpaid service fees of $<span id="xdx_90A_eus-gaap--ProceedsFromRelatedPartyDebt_c20250101__20250930_zLrUjwOwrD1g" title="Amount due to related party"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2025-01-01to2025-09-30" id="Fact000822" format="ixt:numdotdecimal" decimals="0" unitRef="USD">399,798</ix:nonFraction></span> and $<span id="xdx_903_eus-gaap--ProceedsFromRelatedPartyDebt_c20240101__20241231_z0vDsG2trHG2" title="Amount due to related party"><ix:nonFraction name="us-gaap:ProceedsFromRelatedPartyDebt" contextRef="From2024-01-012024-12-31" id="Fact000824" format="ixt:numdotdecimal" decimals="0" unitRef="USD">129,759</ix:nonFraction></span> from
the Sponsor, respectively. The balance is unsecured, interest-free and has no fixed terms of repayment.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Administrative
Services Arrangement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An
affiliate of the Sponsor will agree that, commencing from the date that the Company’s securities are first listed on NASDAQ through
the earlier of the Company’s consummation of a Business Combination and its liquidation, to make available to the Company certain
general and administrative services, including office space, administrative and support services, as the Company may require from time
to time. The Company has agreed to pay the affiliate of the Sponsor $<span id="xdx_903_eus-gaap--GeneralAndAdministrativeExpense_c20250101__20250930__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zRKpMNbVDek3" title="Payment for general and administrative services"><ix:nonFraction name="us-gaap:GeneralAndAdministrativeExpense" contextRef="From2025-01-012025-09-30_custom_SponsorMember" id="Fact000826" format="ixt:numdotdecimal" decimals="0" unitRef="USD">10,000</ix:nonFraction></span> per month for these services commencing on the closing date
of this offering for 9 months (or up to 24 months if the Company extends the Combination Period). As of September 30, 2025 and December
31, 2024, the unpaid services fees of $<span id="xdx_908_ecustom--UnpaidServicesFee_iI_c20250930_zqcuvZDJFIh6" title="Unpaid services fee"><ix:nonFraction name="DYCQ:UnpaidServicesFee" contextRef="AsOf2025-09-30" id="Fact000828" format="ixt:numdotdecimal" decimals="0" unitRef="USD">190,000</ix:nonFraction></span> and $<span id="xdx_907_ecustom--UnpaidServicesFee_iI_c20241231_zXglkkL9jPD7" title="Unpaid services fee"><ix:nonFraction name="DYCQ:UnpaidServicesFee" contextRef="AsOf2024-12-31" id="Fact000830" format="ixt:numdotdecimal" decimals="0" unitRef="USD">100,000</ix:nonFraction></span>, respectively included in due to related party on the unaudited balance sheets.
For the nine months ended September 30, 2025 and 2024, the Company incurred $<span id="xdx_90B_ecustom--IncurredFees_c20250101__20250930_zxJhucrbG8j" title="Incurred fees"><ix:nonFraction name="DYCQ:IncurredFees" contextRef="From2025-01-01to2025-09-30" id="Fact000832" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,000</ix:nonFraction></span> and $<span id="xdx_90E_ecustom--IncurredFees_c20240101__20240930_zKSt5AE3Y7D8" title="Incurred fees"><ix:nonFraction name="DYCQ:IncurredFees" contextRef="From2024-01-012024-09-30" id="Fact000834" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,000</ix:nonFraction></span> in fees for these services, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Working
Capital Loans</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of
the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital
Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds
of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the
Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust
Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans.
Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with
respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest,
or, at the lender’s discretion, up to $<span id="xdx_90A_eus-gaap--RepaymentsOfRelatedPartyDebt_c20250101__20250930__srt--RangeAxis__srt--MaximumMember_zKURLARq7569" title="Related party debt"><ix:nonFraction name="us-gaap:RepaymentsOfRelatedPartyDebt" contextRef="From2025-01-012025-09-30_srt_MaximumMember" id="Fact000836" format="ixt:numdotdecimal" decimals="0" unitRef="USD">300,000</ix:nonFraction></span> of the notes may be converted upon consummation of our business combination into
private units at a price of $<span id="xdx_90A_eus-gaap--BusinessAcquisitionSharePrice_iI_c20250930__us-gaap--BusinessAcquisitionAxis__custom--WorkingCapitalLoansMember_zkumfagsKhxe" title="Conversion price of note"><ix:nonFraction name="us-gaap:BusinessAcquisitionSharePrice" contextRef="AsOf2025-09-30_custom_WorkingCapitalLoansMember" id="Fact000838" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">10.00</ix:nonFraction></span> per unit. As of September 30, 2025 and December 31, 2024, the Company has no principal amount due
and owing under the Working Capital Loans.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Voting agreements</i></b></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company entered into voting agreements with certain
shareholders of the Company (the “Non-Redeeming Shareholders”), pursuant to which these shareholders agreed not to redeem
a portion of their shares of Company ordinary shares (the “Non-Redeemed Shares”) in connection with the extraordinary general
meeting. The Company agrees to issue to such shareholder two Additional SPAC Rights for each Non-redeemed Share. The fair value of $<span id="xdx_903_eus-gaap--StockRedeemedOrCalledDuringPeriodValue_c20250101__20250930__us-gaap--TypeOfArrangementAxis__custom--VotingAgreementsMember_zhoVLkaOi7sh" title="Non redeemed"><ix:nonFraction name="us-gaap:StockRedeemedOrCalledDuringPeriodValue" contextRef="From2025-01-012025-09-30_custom_VotingAgreementsMember" id="Fact000840" format="ixt:numdotdecimal" decimals="0" unitRef="USD">163,022</ix:nonFraction></span>
was determined using the quoted prices in active market of the rights.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 19 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000842" name="us-gaap:DebtDisclosureTextBlock"><p id="xdx_80D_eus-gaap--DebtDisclosureTextBlock_zFw13iJ9Gfj5" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
6 – <span id="xdx_82D_zfWf8fBS3bTh">PROMISSORY NOTE</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 27, 2025, June 18, 2025, June 25, 2025, July 31, 2025, and September 24, 2025, the Company issued five unsecured promissory notes
(the “Notes”) in an amount of $<span id="xdx_901_eus-gaap--UnsecuredDebt_iI_c20250527_zUBMIljiFPZ6" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2025-05-27" id="Fact000844" format="ixt:numdotdecimal" decimals="0" unitRef="USD">201,959</ix:nonFraction></span>, $<span id="xdx_905_eus-gaap--UnsecuredDebt_iI_c20250618_zllnu6oxJnVa" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2025-06-18" id="Fact000846" format="ixt:numdotdecimal" decimals="0" unitRef="USD">251,327</ix:nonFraction></span>, $<span id="xdx_90C_eus-gaap--UnsecuredDebt_iI_c20250625_zjREgQlpyoRj" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2025-06-25" id="Fact000848" format="ixt:numdotdecimal" decimals="0" unitRef="USD">92,689</ix:nonFraction></span>, $<span id="xdx_909_eus-gaap--UnsecuredDebt_iI_c20250731_z8wlMoMnFRfd" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2025-07-31" id="Fact000850" format="ixt:numdotdecimal" decimals="0" unitRef="USD">90,900</ix:nonFraction></span> and $<span id="xdx_906_eus-gaap--UnsecuredDebt_iI_c20250924_zFmAyxQzSR4h" title="Unsecured promissory notes"><ix:nonFraction name="us-gaap:UnsecuredDebt" contextRef="AsOf2025-09-24" id="Fact000852" format="ixt:numdotdecimal" decimals="0" unitRef="USD">78,450</ix:nonFraction></span> to Maius, respectively. These Notes do not
bear interest and mature upon the closing of a business combination by the Company. In the event that the Company does not complete an
initial business combination by December 23, 2025 (as such deadline may be further extended), the Note shall be deemed to be terminated
and no amounts will thereafter be due from the Company to the Sponsor under the Note.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025 and December 31, 2024, Maius advanced the Company an aggregate amount of $<span id="xdx_900_eus-gaap--SecuredDebtCurrent_iI_c20250930_ztsSJ78uAZ45" title="Secured debt, current"><ix:nonFraction name="us-gaap:SecuredDebtCurrent" contextRef="AsOf2025-09-30" id="Fact000854" format="ixt:numdotdecimal" decimals="0" unitRef="USD">715,325</ix:nonFraction></span> and $<span id="xdx_901_eus-gaap--SecuredDebtCurrent_iI_dxL_c20241231_zIJ4ncj3viAc" title="Secured debt, current::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl0856">0</span></span>, respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000858" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock"><p id="xdx_80D_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zRWl8fMfg5Ki" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
7 – <span id="xdx_821_zVPLS7iuqKG5">SHAREHOLDERS’ DEFICIT</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.6pt; text-align: justify; text-indent: -28.6pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Ordinary
shares</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company is authorized to issue <span id="xdx_905_eus-gaap--CommonStockSharesAuthorized_iI_pid_c20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zJZ1Exl7zcxd" title="Ordinary shares, shares authorized"><ix:nonFraction name="us-gaap:CommonStockSharesAuthorized" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" id="Fact000860" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">500,000,000</ix:nonFraction></span> ordinary shares at par value of $<span id="xdx_904_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zokuVJuqZZR" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2025-09-30_us-gaap_CommonStockMember" id="Fact000862" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span>. <span id="xdx_90B_eus-gaap--CommonStockVotingRights_c20250101__20250930__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zpAJVfsPgyyg" title="Voting rights"><ix:nonNumeric contextRef="From2025-01-012025-09-30_us-gaap_CommonStockMember" id="Fact000864" name="us-gaap:CommonStockVotingRights">Holders of the Company’s ordinary shares are
entitled to one vote for each share.</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025 and December 31, 2024, <span id="xdx_90E_eus-gaap--CommonStockSharesIssued_iI_pid_c20250930_zso5iY9vQ0lh" title="Ordinary shares, shares issued"><span id="xdx_907_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20250930_zAFqdILKZjuj" title="Ordinary shares, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2025-09-30" id="Fact000866" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2025-09-30" id="Fact000868" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span> and <span id="xdx_906_eus-gaap--CommonStockSharesIssued_iI_pid_c20241231_zIJe8RPL9ay3" title="Ordinary shares, shares issued"><span id="xdx_909_eus-gaap--CommonStockSharesOutstanding_iI_pid_c20241231_zAJp3C61TeBl" title="Ordinary shares, shares outstanding"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-12-31" id="Fact000870" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares"><ix:nonFraction name="us-gaap:CommonStockSharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000872" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,063,000</ix:nonFraction></ix:nonFraction></span></span> Ordinary Shares were issued and outstanding excluding <span id="xdx_901_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20250930_zRAUwcglmUm9" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2025-09-30" id="Fact000874" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">143,382</ix:nonFraction></span> and
<span id="xdx_905_eus-gaap--TemporaryEquitySharesOutstanding_iI_pid_c20241231_zoX2KU7u3PPk" title="Temporary equity, shares outstanding"><ix:nonFraction name="us-gaap:TemporaryEquitySharesOutstanding" contextRef="AsOf2024-12-31" id="Fact000876" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,900,000</ix:nonFraction></span> shares subject to possible redemption, respectively, so that the initial shareholders will own 20% of the issued and outstanding
shares after the Initial Public Offering (excluding the sale of the Private Units and assuming the initial shareholders do not purchase
any Units in the Initial Public Offering). As a result of the underwriters’ full exercise of their over-allotment option on February
23, 2024, no Founder Shares are currently subject to forfeiture.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights
</b>— <span id="xdx_904_eus-gaap--CommonStockVotingRights_c20250101__20250930_zzjE1KsE4xTa" title="Common stock rights"><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" id="Fact000878" name="us-gaap:CommonStockVotingRights">Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if
the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued
upon exchange of the rights.</ix:nonNumeric></span> No additional consideration will be required to be paid by a holder of rights in order to receive its additional
shares upon consummation of a Business Combination as the consideration related thereto has been included in the Unit purchase price
paid for by investors in the Initial Public Offering. If the Company enters into a definitive agreement for a Business Combination in
which the Company will not be the surviving entity, the definitive agreement will provide for the holders of rights to receive the same
per share consideration the holders of the ordinary shares will receive in the transaction on an as-converted into ordinary share basis
and each holder of a right will be required to affirmatively convert its rights in order to receive 1/7 share underlying each right (without
paying additional consideration). The shares issuable upon exchange of the rights will be freely tradable (except to the extent held
by affiliates of the Company).</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 20 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000880" name="us-gaap:FairValueDisclosuresTextBlock"><p id="xdx_804_eus-gaap--FairValueDisclosuresTextBlock_zCdM9cPMrYbc" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
8 – <span id="xdx_821_zW7ZJUmz21m7">FAIR VALUE MEASUREMENTS</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would
have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction
between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company
seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable
inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is
used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and
liabilities:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
1:</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted
prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions
for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
2:</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Observable
inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities
and quoted prices for identical assets or liabilities in markets that are not active.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level
3:</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unobservable
inputs based on the assessment of the assumptions that market participants would use in pricing the asset or liability.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000882" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock"><p id="xdx_892_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock_zE0gwxZBoNWi" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table presents information about the Company’s assets that are measured at fair value on a recurring basis as of September
30, 2025 and December 31, 2024, respectively and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine
such fair value.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zwyVrq4WvRH4" style="display: none">SCHEDULE
OF ASSETS MEASURED AT FAIR VALUE ON A RECURRING BASIS</span></span></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="vertical-align: bottom">
<td> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_490_20250930__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zDOgXxdUS4yg" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">September 30, 2025</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_497_20250930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zcbxKTlU6ief" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Quoted<br/> Prices in<br/> Active Markets<br/> (Level 1)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_499_20250930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zaoKpfZKGC78" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Observable<br/> Inputs<br/> (Level 2)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1pt"> </td>
<td colspan="2" id="xdx_497_20250930__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zy4txFoqsvcc" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Significant<br/> Other<br/> Unobservable<br/> Inputs<br/> (Level 3)</td><td style="padding-bottom: 1pt; font-weight: bold"> </td></tr>
<tr id="xdx_409_eus-gaap--AssetsAbstract_iB_z52cGcdCKJre" style="vertical-align: bottom; background-color: rgb(204,238,255)">
<td style="font-weight: bold">Assets</td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td>
<td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr>
<tr id="xdx_40F_eus-gaap--AssetsHeldInTrustCurrent_i01I_zvacFFOD0kAh" style="vertical-align: bottom; background-color: White">
<td style="width: 44%; text-align: left; padding-bottom: 2.5pt">Cash and Investments held in trust account</td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2025-09-30_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000889" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,598,106</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2025-09-30_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000890" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,598,106</ix:nonFraction></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl0891">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 2.5pt"> </td>
<td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; width: 10%; text-align: right">         <span style="-sec-ix-hidden: xdx2ixbrl0892">-</span></td><td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td colspan="2" id="xdx_498_20241231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zvNUbMWwct48" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>December
31, 2024</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td colspan="2" id="xdx_495_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_zxSuMSJk7C7a" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Quoted<br/>
Prices in<br/>
Active Markets<br/>
(Level 1)</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td colspan="2" id="xdx_493_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_ztOeiz5tpcMi" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other<br/>
Observable<br/>
Inputs<br/>
(Level 2)</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td colspan="2" id="xdx_49B_20241231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember_z7FeDCz66t2g" style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Significant<br/>
Other<br/>
Unobservable<br/>
Inputs<br/>
(Level 3)</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr>
<tr id="xdx_400_eus-gaap--AssetsAbstract_iB_zSXr9EFib30i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr id="xdx_405_eus-gaap--AssetsHeldInTrustCurrent_i01I_zuMqHyLm8eZ6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white">
<td style="font: 10pt Times New Roman, Times, Serif; width: 44%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash
and Investments held in trust account</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000899" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,345,071</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:nonFraction name="us-gaap:AssetsHeldInTrustCurrent" contextRef="AsOf2024-12-31_us-gaap_FairValueInputsLevel1Member_us-gaap_FairValueMeasurementsRecurringMember" id="Fact000900" format="ixt:numdotdecimal" decimals="0" unitRef="USD">72,345,071</ix:nonFraction></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">      <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0901">-</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
<td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">       <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl0902">-</span></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
</table>
</ix:nonNumeric><p id="xdx_8AC_z1u9neiW3923" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000904" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock"><p id="xdx_800_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zFjZtZuUp48k" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
9 – <span id="xdx_820_zKQbH33IlZ4g">COMMITMENTS AND CONTINGENCIES</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management
is currently assessing to evaluate the impact of the Russia-Ukraine war and the conflict in Israel and Palestine on the industry and
has concluded that these events are outside of Company’s control and may arise from time to time may adversely affect the global
economy or capital markets, and the business of any potential target business with which the Company may consummate a business combination
could be materially and adversely affected and the specific impact is not readily determinable as of the date of these unaudited financial
statements. The unaudited financial statements do not include any adjustments that might result from the outcome of this uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<ix:exclude><!-- Field: Page; Sequence: 21 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page --></ix:exclude>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
CLOUD ACQUISITION CORPORATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTES
TO UNAUDITED FINANCIAL STATEMENTS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Registration
Rights</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on February 23, 2024, the holders of the Founder Shares, Private Placement Units (including
securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital
loans or extension loans (and) are entitled to registration rights pursuant to a registration rights agreement signed on the effective
date of this offering requiring the Company to register such securities for resale. The holders of these securities are entitled to make
up to three demands, excluding short form demands, that the Company’s register such securities. In addition, the holders have certain
“piggy-back” registration rights with respect to registration statements filed subsequent to the Company completion of initial
business combination and rights to require the Company to register for resale such securities pursuant to Rule 415 under the Securities
Act. The Company will bear the expenses incurred in connection with the filing of any such registration statements</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Underwriter
Agreement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--UnderwritingCommitments_c20250101__20250930__us-gaap--TypeOfArrangementAxis__custom--UnderwriterAgreementMember_zJl1HbvLn5fg" title="Underwriting commitments, description"><ix:nonNumeric contextRef="From2025-01-012025-09-30_custom_UnderwriterAgreementMember" id="Fact000906" name="us-gaap:UnderwritingCommitments">The
underwriters are entitled to a cash underwriting discount of <span id="xdx_90E_ecustom--PercentageOfUnderwritingFees_pid_dp_uPure_c20250101__20250930__us-gaap--TypeOfArrangementAxis__custom--UnderwriterAgreementMember_zvN6NFYivIz1" title="Percentage of underwriting fees"><ix:nonFraction name="DYCQ:PercentageOfUnderwritingFees" contextRef="From2025-01-012025-09-30_custom_UnderwriterAgreementMember" id="Fact000908" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.5</ix:nonFraction></span>% of the gross proceeds of the Initial Public Offering, or $<span id="xdx_905_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_c20250101__20250930__us-gaap--TypeOfArrangementAxis__custom--UnderwriterAgreementMember_zBFxuFGddnh4" title="Business combination"><ix:nonFraction name="us-gaap:BusinessCombinationPriceOfAcquisitionExpected" contextRef="From2025-01-012025-09-30_custom_UnderwriterAgreementMember" id="Fact000910" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,725,000</ix:nonFraction></span>,
upon the closing of the Business Combination.</ix:nonNumeric></span></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2024, the Company issued <span id="xdx_901_eus-gaap--CommonStockSharesIssued_iI_c20240223__dei--LegalEntityAxis__custom--BrooklineCapitalMarketsMember__us-gaap--TypeOfArrangementAxis__custom--UnderwriterAgreementMember_ztKePcRODmw4" title="Ordinary shares, shares issued"><ix:nonFraction name="us-gaap:CommonStockSharesIssued" contextRef="AsOf2024-02-23_custom_BrooklineCapitalMarketsMember_custom_UnderwriterAgreementMember" id="Fact000912" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">103,500</ix:nonFraction></span> ordinary shares of $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20240223__dei--LegalEntityAxis__custom--BrooklineCapitalMarketsMember__us-gaap--TypeOfArrangementAxis__custom--UnderwriterAgreementMember_zPp9PxqVPJT2" title="Ordinary shares, par value"><ix:nonFraction name="us-gaap:CommonStockParOrStatedValuePerShare" contextRef="AsOf2024-02-23_custom_BrooklineCapitalMarketsMember_custom_UnderwriterAgreementMember" id="Fact000914" format="ixt:numdotdecimal" decimals="INF" unitRef="USDPShares">0.0001</ix:nonFraction></span> par value each to Brookline Capital Markets, a division of Arcadia
Securities (hereafter – the Representative Shares), at the closing of the IPO as part of representative compensation.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000916" name="us-gaap:SegmentReportingDisclosureTextBlock"><p id="xdx_80B_eus-gaap--SegmentReportingDisclosureTextBlock_zfDdimQCDGf1" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
10 – <span id="xdx_82A_z3ilVJ5R7K9b">SEGMENT INFORMATION</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC
Topic 280, “Segment Reporting,” establishes standards for companies to report in their unaudited financial statement information
about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of
an enterprise for which separate financial information is available that is regularly evaluated by the Company’s chief operating
decision maker (“CODM”), or group, in deciding how to allocate resources and assess performance.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company’s CODM has been identified as the Chief Financial Officer, who reviews the operating results for the Company as a whole
to make decisions about allocating resources and assessing financial performance. Accordingly, management has determined that the Company
only has one operating segment.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
key measures of segment profit or loss reviewed by the CODM are interest income and dividend income earned on cash and investments held
in trust account and formational and operating costs. The CODM reviews interest income and dividend income earned on cash and investments
held in trust account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust
Account funds while maintaining compliance with the trust agreement. Formational and operating costs are reviewed and monitored by the
CODM to manage and forecast cash to ensure enough capital is available to complete a business combination within the business combination
period. The CODM also reviews formational and operating costs to manage, maintain and enforce all contractual agreements to ensure costs
are aligned with all agreements and budget.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
</ix:nonNumeric><ix:nonNumeric contextRef="From2025-01-01to2025-09-30" escape="true" id="Fact000918" name="us-gaap:SubsequentEventsTextBlock"><p id="xdx_80B_eus-gaap--SubsequentEventsTextBlock_z3Ys9LeycJt8" style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.65pt; text-align: justify; text-indent: -28.65pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE
11 – <span id="xdx_826_zfTE42VUrWQa">SUBSEQUENT EVENTS</span></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the unaudited financial
statements were issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the unaudited
financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On November 19, 2025, the Company issued unsecured
promissory note in an amount of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_c20251119__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--UnsecuredPromisssoryNoteMember_zkL8GBPmhWP9"><ix:nonFraction name="us-gaap:DebtInstrumentFaceAmount" contextRef="AsOf2025-11-19_us-gaap_SubsequentEventMember_custom_UnsecuredPromisssoryNoteMember" id="Fact000919" format="ixt:numdotdecimal" decimals="0" unitRef="USD">70,287</ix:nonFraction></span> to Maius. This promissory note does not bear interest and mature upon the closing of a business
combination.</p>
</ix:nonNumeric><p id="xdx_817_zoXFModmTKO8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 22 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-003"></span>ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>References
in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to DT Cloud
Acquisition Corporation. References to our “management” or our “management team” refer to our officers and directors,
and references to the “Sponsor” refer to DT Cloud Capital Corp. The following discussion and analysis of the Company’s
financial condition and results of operations should be read in conjunction with the unaudited financial statements and the notes thereto
contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking
statements that involve risks and uncertainties.</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Special
Note Regarding Forward-Looking Statements</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
Quarterly Report includes “forward-looking statements” that are not historical facts and involve risks and uncertainties
that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical
fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans
and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,”
“anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions
are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance,
but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events,
performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For
information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking
statements, please refer to the Risk Factors section of the Company’s final prospectus for its initial public offering filed with
the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except
as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking
statements whether as a result of new information, future events or otherwise.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Overview</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are a blank check company incorporated in the Cayman Islands on July 7, 2022 as an exempted company with limited liability. We were formed
for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar
business combination with one or more businesses or entities, which we refer to as a “target business.” We are an emerging
growth company and, as such, we are subject to all of the risks associated with emerging growth companies.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2024, we consummated the initial public offering of 6,900,000 units, which includes the exercise in full by the underwriters
of their over-allotment option to purchase up to an additional 900,000 units on February 21, 2024. Each unit consists of one ordinary
share and one right. Each seven rights entitle the holder thereof to receive one ordinary share at the closing of a business combination.
The units were sold at an offering price of $10.00 per unit, generating gross proceeds of $69,000,000. Simultaneously with the closing
of our initial public offering on February 23, 2024, we consummated the private placement with DT Cloud Capital Corp., our sponsor, of
234,500 units at a price of $10.00 per private unit, generating total gross proceeds of $2,345,000. As of February 23, 2024, a total
of $69,345,000 of the net proceeds from our initial public offering and the private placement were deposited in a trust account established
for the benefit of our public stockholders at Morgan Stanley, with Continental Stock Transfer & Trust Company, acting as trustee.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 23; Options: NewSection; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
units started to be listed on The Nasdaq Global Market (the “Nasdaq”) and began trading under the ticker symbol “DYCQU”
on February 21, 2024. On April 10, 2024, we announced that the holders of the units may elect to separately trade the underlying component
securities of the units commencing on April 12, 2024. Those units not separated will continue to trade on Nasdaq under the symbol “DYCQU,”
and each of the ordinary shares and rights that are separated will trade on Nasdaq under the symbols “DYCQ” and “DYCQR,”
respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our
initial business combination either (i) in connection with a shareholder meeting called to approve the business combination or (ii) by
means of a tender offer. The decision as to whether we will seek shareholder approval of a proposed business combination or conduct a
tender offer will be made by us, solely in our discretion, and will be based on a variety of factors such as the timing of the transaction
and whether the terms of the transaction would require us to seek shareholder approval under the law or stock exchange listing requirement.
The amount in the Trust Account is initially anticipated to be $10.05 per public share (subject to increase of up to an additional $0.03
per public share for each monthly extension in the event that the Sponsor elects to extend the period of time to consummate a business
combination). The per-share amount we will distribute to investors who properly redeem their shares will not be reduced by the deferred
underwriting commissions we will pay to the underwriters. There will be no redemption rights upon the completion of our initial business
combination with respect to our rights. The Sponsor, officers and directors have entered into a letter agreement with us, pursuant to
which they have agreed to waive their redemption rights with respect to their founder shares, private placement shares and any public
shares they may acquire during or after our initial public offering in connection with the completion of our initial business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
we have entered into a definitive business combination agreement on October 22, 2024 (the “Business Combination Agreement”),
which is within nine months after the closing of our initial public offering, we have been entitled to an automatic three-month extension
to the original nine months from the closing of our initial public offering to consummate our initial business combination. We now have
21 months from the closing of our initial public offering to consummate our initial business combination if we extend the period of time
to consummate a business combination, which may be accomplished only if our insiders or their affiliates or designees deposit additional
funds into the Trust Account. We will use our reasonable best efforts to cause the our board of directors to extend the date by which
we must consummate a business combination to February 23, 2027 (such period by which we must consummate a business combination,
as amended, and as may be extended in accordance with the provisions of the Business Combination Agreement, the “Combination Period”),
provided that our insiders or their affiliates or designees deposit additional funds into the Trust Account. From February 2025 to July
2025, the Company using the funds held outside the Trust Account, the Company made five times deposit for an aggregate of $679,091, to
the Trust Account and extended the Combination Period from February 24, 2025 to August 23, 2025. On August 21, 2025, an ordinary resolution
approved at the Extraordinary General Meeting, the monthly fee waiver will become operative beginning on August 23, 2025, and the 23rd
of each succeeding month until the earlier of the closing of an initial business combination or February 23, 2027.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we are unable to consummate an initial business combination within the Combination Period, we will, (1) cease all operations except for
the purpose of winding up; (2) as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public
shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest
earned on the funds held in the trust account and not previously released to us to pay our income taxes, divided by the number of the
then-outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including
the right to receive further liquidation distributions, if any); and (3) as promptly as reasonably possible following such redemption,
subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in the case of clauses
(2) and (3), to our obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable
law.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proposed
Business Combination</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, we entered into the Business Combination Agreement with Maius Pharmaceutical Co., Ltd., an exempted company limited
by shares incorporated under the laws of the Cayman Islands (“Maius”), Maius Pharmaceutical Group Co., Ltd., an exempted
company limited by shares incorporated under the laws of the Cayman Islands (“Pubco”) incorporated for the purpose of serving
as the public listed company whose shares shall be traded on Nasdaq, Chelsea Merger Sub 1 Limited, a Cayman Islands exempted company
(“Merger Sub 1”), Chelsea Merger Sub 2 Limited, a Cayman Islands exempted company (“Merger Sub 2”), and XXW Investment
Limited, a limited liability company incorporated under the laws of British Virgin Islands as the Company shareholders’ representative
(the “Shareholders’ Representative”). The mergers and each of the other transactions contemplated by the Business Combination
Agreement or other ancillary documents are collectively referred to as the “Business Combination.”</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 24; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Termination</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement may be terminated under certain customary and limited circumstances prior to the Closing (as defined in
the Business Combination Agreement), including, among others: (i) by mutual written consent of us and Maius; (ii) by us or Maius if the
Closing has not occurred on or before June 30, 2025 (the “Outside Date”); (iii) by us or Maius if any law or governmental
order is in effect that has become final and non-appealable and has the effect of making the consummation of the Transactions illegal
or otherwise preventing or prohibiting consummation of the Transactions (as defined in the Business Combination Agreement); (iv) by either
us or Maius if it is not in material breach of any of its obligations hereunder while the other party is in material breach of any of
its representations, warranties or obligations hereunder that renders or could reasonably be expected to render the conditions set forth
in the Business Combination Agreement incapable of being satisfied on the Outside Date, and such breach cannot or has not been cured;
(v) by us if we are not in material breach of any of our obligations hereunder and Maius fails to perform certain covenants set forth
in the Business Combination Agreement within the time period promulgated therein; and (vi) by either us or Maius, if we fail to obtain
the required shareholder approval upon vote taken thereon at a duly convened special meeting of shareholders.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Business Combination Agreement and related agreements are further described in our Current Report on Form 8-K filed with the SEC on October
23, 2024. Other than as specifically discussed, this Quarterly Report does not assume the closing of the Business Combination or the
transactions contemplated by the Business Combination Agreement.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Form
of Sponsor Support and Lock-up Agreement</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the execution and delivery of the Business Combination Agreement, the Sponsor has executed and delivered to Maius a support and
lock-up agreement (the “Sponsor Support and Lock-up Agreement”), pursuant to which, the Sponsor has agreed to, among other
things, (i) vote to adopt and approve the Business Combination Agreement, the Ancillary Agreements and the Transactions contemplated
hereunder, and (ii) become subject to certain lock-up provisions with respect to certain Restricted Securities (as defined in the Sponsor
Support and Lock-up Agreement) held by it.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
foregoing description of the Sponsor Support and Lock-up Agreement does not purport to be complete and is qualified in its entirety by
the terms and conditions of the Sponsor Support and Lock-up Agreement, a copy of which is filed with our Current Report on Form 8-K filed
with the SEC on October 23, 2024, which is incorporated by reference herein.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Going
Concern Consideration</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company initially had 9 months from the consummation of the Initial Public Offering to consummate the initial Business Combination. If
the Company does not complete a Business Combination within nine months from the consummation of the Initial Public Offering, the Company
will trigger an automatic winding up, dissolution and liquidation pursuant to the terms of the Amended and Restated Memorandum and Articles
of Association. As a result, this has the same effect as if the Company had formally gone through a voluntary liquidation procedure under
the Companies Act (As Revised) of the Cayman Islands. Accordingly, no vote would be required from our shareholders to commence such a
voluntary winding up, dissolution and liquidation. However, the Company may extend the period of time to consummate a Business Combination
twenty-four times (for a total of up to 33   months from the consummation of the Initial Public Offering to complete a Business
Combination). If the Company is unable to consummate the Company’s initial Business Combination by February 23, 2027   (unless
further extended), the Company will, as promptly as possible but not more than ten business days thereafter, redeem 100% of the Company’s
outstanding public shares for a pro rata portion of the funds held in the Trust Account, including a pro rata portion of any interest
earned on the funds held in the Trust Account and not necessary to pay taxes, and then seek to liquidate and dissolve. However, the Company
may not be able to distribute such amounts as a result of claims of creditors which may take priority over the claims of the Company’s
public shareholders. In the event of dissolution and liquidation, the Company’s rights will expire and will be worthless.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 25; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management plans to address this uncertainty through the initial business combination as discussed above. There is no assurance that
our plans to consummate the initial business combination will be successful or successful by the deadline of completing an initial business
combination as described above. The unaudited financial statements do not include any adjustments that might result from the outcome
of this uncertainty.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Risks
and Uncertainties</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are currently experiencing a period of economic uncertainty and capital markets disruption, which has been significantly impacted by
geopolitical instability and economic uncertainties. For example, United States and global markets are experiencing volatility and disruption
following the geopolitical instability resulting from the ongoing Russia-Ukraine conflict and the escalation of the Israel-Hamas conflict.
In response to the ongoing Russia-Ukraine conflict, the North Atlantic Treaty Organization (“NATO”) deployed additional military
forces to eastern Europe, and the United States, the United Kingdom, the European Union and other countries have announced various sanctions
and restrictive actions against Russia, Belarus and related individuals and entities, including the removal of certain financial institutions
from the Society for Worldwide Interbank Financial Telecommunication (SWIFT) payment system. Certain countries, including the United
States, have also provided and may continue to provide military aid or other assistance to Ukraine and to Israel, increasing geopolitical
tensions among a number of nations. The Russia-Ukraine conflict and the escalation of the Israel Hamas conflict and the resulting measures
that have been taken, and could be taken in the future, by NATO, the United States, the United Kingdom, the European Union, Israel and
its neighboring states and other countries have created global security concerns that could have a lasting impact on regional and global
economies. Although the length and impact of the ongoing conflicts are highly unpredictable, they could lead to market disruptions, including
significant volatility in commodity prices, credit and capital markets, as well as supply chain interruptions and increased cyber-attacks
against U.S. companies. Additionally, any resulting sanctions could adversely affect the global economy and financial markets and lead
to instability and lack of liquidity in capital markets. The political and economic intense between the United States and China may also
affect the business of the target of our Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
search for a business combination, and any target business with which we ultimately consummate a business combination, may be materially
adversely affected by any negative impact on the global economy and capital markets resulting from the conflict in geopolitical tensions
and economic uncertainties.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liquidity
and Capital Resources</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2024, we consummated the initial public offering of 6,900,000 units, which includes the exercise in full by the underwriters
of their over-allotment option to purchase up to an additional 900,000 units on February 21, 2024. The units were sold at an offering
price of $10.00 per unit, generating gross proceeds of $69,000,000. Simultaneously with the closing of our initial public offering on
February 23, 2024, we consummated the private placement with DT Cloud Capital Corp., our sponsor, of 234,500 units at a price of $10.00
per private unit, generating total gross proceeds of $2,345,000.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
our initial public offering and the private placement, a total of $69,345,000 of the net proceeds from our initial public offering and
the private placement were deposited in the trust account. We intend to use substantially all of the funds held in the trust account,
including any amounts representing interest earned on the trust account (excluding deferred underwriting commissions and less taxes payable)
to complete our initial business combination. We may withdraw interest from the trust account to pay our taxes. To the extent that our
equity or debt is used, in whole or in part, as consideration to complete our initial business combination, the remaining proceeds held
in the trust account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions
and pursue our growth strategies. We intend to use the funds held outside the trust account primarily for identifying and evaluating
prospective acquisition candidates, performing business due diligence on prospective target businesses, traveling to and from the offices,
plants or similar locations of prospective target businesses, reviewing corporate documents and material agreements of prospective target
businesses, selecting the target business to acquire and structuring, negotiating and consummating the business combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 26; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the nine months ended September 30, 2025, cash used in operating activities was $647,743, primarily due to net income of $444,595,
as adjusted by change in operating assets and liabilities that positively affected our cash flows, including non-redemption
agreement expense of $163,022 and increase in due to related party of $110,551, partially offset by dividend income earned on cash
and investment held in trust account of $1,333,491, changes in operating assets and liabilities that negatively affected our cash
flow, including prepaid expenses of $6,041 and accrued liabilities of $26,379.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025, we had cash in bank of $0.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
May 27, 2025, June 18, 2025, June 25, 2025, July 31, 2025, September 24, 2025 and November 19, 2025, we issued three unsecured
promissory notes (the “Notes”) in an amount of $201,959, $251,327, $92,689, $90,900, $78,450 and $70,287 to Maius,
respectively. These Notes do not bear interest and mature upon the closing of a business combination by the Company. In the event
that the Company does not complete an initial business combination by December 23, 2025 (as such deadline may be further extended),
the Note shall be deemed to be terminated and no amounts will thereafter be due from the Company to the Sponsor under the Note. As
of September 30, 2025 and December 31, 2024, the Sponsor advanced the Company an aggregate amount of $715,325 and $0,
respectively.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025 and December 31, 2024, we had a temporary advance and unpaid service fees of $399,798 and $129,759 from the sponsor,
respectively. The balance is unsecured, interest-free and has no fixed terms of repayment.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
order to fund working capital deficiencies or finance transaction costs in connection with an initial business combination, our sponsor,
officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required (“Working Capital Loan”).
If we complete our initial business combination, we will repay such loaned amounts. In the event that the initial business combination
does not close, we may use a portion of the working capital held outside the trust account to repay such loaned amounts, but no proceeds
from our trust account would be used for such repayment. Up to $300,000 of such loans may be convertible upon consummation of our business
combination into private units at a price of $10.00 per unit. As of September 30, 2025 and December 31, 2024, there was no outstanding
balance of the principal amount due under the Working Capital Loan.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Results
of Operations</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
entire activity since inception up to September 30, 2025 related to our formation, the preparation for the initial public offering, and
since the closing of the initial public offering, the search for a prospective initial business combination. We will not be generating
any operating revenues until the closing and completion of our initial business combination, at the earliest. We will generate non-operating
income in the form of interest income from the amount held in the Trust Account.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contractual
Obligations</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Registration
Rights</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to a registration rights agreement entered into on February 23, 2024, the holders of the insider shares, private placement units (including
securities contained therein), and units (including securities contained therein) that may be issued on conversion of working capital
loans or extension loans (and) are entitled to registration rights pursuant to a registration rights agreement signed on the effective
date of our initial public offering requiring us to register such securities for resale. The holders of these securities are entitled
to make up to three demands, excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back”
registration rights with respect to registration statements filed subsequent to our completion of initial business combination and rights
to require us to register for resale such securities pursuant to Rule 415 under the Securities Act. We will bear the expenses incurred
in connection with the filing of any such registration statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 27; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Underwriting
Agreement</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
underwriters are to receive a cash underwriting discount of 2.5% of the gross proceeds of the initial public offering, or $1,725,000,
upon the closing of the initial business combination. On February 23, 2024 we issued 103,500 ordinary shares of $0.0001 par value each
to Brookline Capital Markets, a division of Arcadia Securities, at the closing of our initial public offering as part of representative
compensation, which has been received by Brookline.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Administrative
Services Agreement</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 20, 2024, we entered into an agreement with our sponsor, pursuant to which we agreed to pay our sponsor a total of $10,000 per
month for secretarial and administrative support services provided to us through the earlier of consummation of the initial business
combination and our liquidation. As of September 30, 2025 and December 31, 2024, the unpaid services fees of $190,000 and $100,000, respectively
included in due to related party on the balance sheet.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, our sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses
incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on
suitable business combinations. There is no cap or ceiling on the reimbursement of out-of-pocket expenses incurred by such persons in
connection with activities on our behalf.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Business
Combination Agreement</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
October 22, 2024, we entered into the Business Combination Agreement with Maius, Pubco, Merger Sub 1, Merger Sub 2 and XXW Investment
Limited. The merger involves multiple steps and will result in the cancellation and conversion of various shares into Pubco’s ordinary
shares. After the Closing of the transactions contemplated by the Business Combination Agreement, we will become a wholly owned subsidiary
of Pubco. The Closing is subject to various conditions, such as shareholder approvals and regulatory clearances (including the necessary
approval from the China Securities Regulatory Commission). Additionally, related agreements such as the Key Company Shareholder Lock-Up
agreement, Key Company Shareholder Support agreement, and Sponsor Support and Lock-up Agreement (as defined in the Business Combination
Agreement) have been executed. See our Current Report on Form 8-K filed with the SEC on October 23, 2024 for details.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Critical
Accounting Estimates</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
preparation of financial statements and related disclosures in conformity with U.S. GAAP requires management to make estimates and assumptions
that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial
statements, and the reported amounts of income and expenses during the periods reported. Actual results could materially differ from
those estimates. We have not identified any critical accounting estimates.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Recent
Accounting Pronouncements</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have
a material effect on the Company’s unaudited financial statements.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Off-Balance
Sheet Arrangements</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<!-- Field: Page; Sequence: 28; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>JOBS
Act</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
qualify as an “emerging growth company” under the JOBS Act and are allowed to comply with new or revised accounting pronouncements
based on the effective date for private (not publicly traded) companies. We elected to delay the adoption of new or revised accounting
standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such
standards is required for non-emerging growth companies. As a result, our financial statements may not be comparable to companies that
comply with new or revised accounting pronouncements as of public company effective dates.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
an “emerging growth company”, we are not required to, among other things, (1) provide an auditor’s attestation report
on our system of internal controls over financial reporting pursuant to Section 404, (2) provide all of the compensation disclosure that
may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (3) comply
with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s
report providing additional information about the audit and the financial statements (auditor discussion and analysis), and (4) disclose
certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of
the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion
of our initial public offering or until we are no longer an “emerging growth company,” whichever is earlier.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-004"></span>Item
3. Quantitative and Qualitative Disclosures About Market Risk</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
item is not applicable as we are a smaller reporting company.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-005"></span>Item
4. Controls and Procedures</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Evaluation
of Disclosure Controls and Procedures</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Disclosure
controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded,
processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is
accumulated and communicated to our management, including our principal executive officer and principal financial and accounting officer
or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the supervision and with the participation of our management, including our principal executive officer and principal financial officer,
we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of September 30, 2025, as such term is defined
in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial
officer have concluded that during the period covered by this Report, our disclosure controls and procedures were not effective as of
September 30, 2025, because of the identification of the material weaknesses in our internal control over financial reporting relating
to (1) inadequate segregation of duties within account processes due to limited personnel, and (2) insufficient written policies and
procedure for accounting, IT, financial reporting and record keeping. In light of these material weaknesses, we performed additional
analysis as deemed necessary to ensure that our financial statements were prepared in accordance with U.S. GAAP. Accordingly, management
believes that the financial statements included in this Report present fairly in all material respects our financial position, results
of operations and cash flows for the periods presented<b><i>.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
in Internal Control Over Financial Reporting</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During
the most recently completed fiscal quarter, there has been no change in our internal control over financial reporting (as defined in
Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that has materially affected, or is reasonably likely to materially affect, our
internal control over financial reporting.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<!-- Field: Page; Sequence: 29; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-006"></span>PART
II - OTHER INFORMATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-007"></span>ITEM
1. LEGAL PROCEEDINGS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-008"></span>ITEM
1A. RISK FACTORS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Except
as set forth below, as of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed
in our annual report on Form 10-K filed with the SEC on March 27, 2025, as amended on June 16, 2025. We may disclose changes to such
factors or disclose additional factors from time to time in our future filings with the SEC.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
we fail to meet applicable continued listing requirements, Nasdaq may delist our securities from trading, in which case the liquidity
and market price of our securities could decline.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 22, 2025, August 25, 2025 and September 25, 2025, we received deficiency letters (each a “Notice” and together, the
“Notices”) from the Listing Qualifications Department of Nasdaq notifying the us that:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated in the Notice dated August 22, 2025, for the 30 consecutive business days from June
30, 2025 to August 21, 2025, the minimum Market Value of Listed Securities, as defined by
Nasdaq (“MVLS”), of the Company had been below the minimum $50 million requirement
for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A)
(the “MVLS Requirement”);</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated in the Notice dated August 25, 2025, the number of publicly held shares, as reported
in the Company’s proxy statement filed on August 11, 2025, was below the minimum 1,100,000
Publicly Held Shares requirement for continued listing on the Nasdaq Global Market under
Nasdaq Listing Rule 5450(b)(2)(B) (the “Public Shares Requirement”); and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
stated in the Notice dated September 25, 2025, for the 30 consecutive business days from
August 8, 2025 to September 24, 2025, the minimum Market Value of Publicly Held Shares (“MVPHS”)
had been below the minimum $15 million requirement for continued listing on the Nasdaq Global
Market under Nasdaq Listing Rule 5450(b)(2)(C) (the “MVPHS Requirement”, and
together with the MVLS Requirement and Public Shares Requirement, the “Listing Requirements”).</span></td></tr></table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relation to the MVLS Requirement, the Company has been provided a cure period of 180 calendar days, or until February 18, 2026 (“MVLS
Cure Period”), regain compliance with the MVLS Requirement. To regain compliance, the MVLS must meet or exceed $50,000,000 for
at least 10 consecutive business days during the MVLS Cure Period.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relation to the Public Shares Requirement, the Company was granted 45 calendar days, from the date of the Notice (August 25, 2025), to
submit a plan to regain compliance (“Plan”). Accordingly, the Company submitted to Nasdaq its plan to regain compliance on
October 9, 2025. Upon Nasdaq’s acceptance of such plan, the company may be granted an extension of up to 180 calendar days form
the date of the Notice (August 25, 2025) to evidence compliance.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
relation to the MVPHS Requirement, the Company has been provided a cure period of 180 calendar days, or until March 24, 2026 (“MVPHS
Cure Period”, together with MVLS Cure Period, the “Cure Periods”), to regain compliance with the MVPHS Requirement.
To regain compliance, the MVPHS must meet or exceed $15,000,000 for at least 10 consecutive business days during the MVPHS Cure Period</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
Nasdaq does not accept the Plan or if the Company fails to regain compliance with the Listing Requirements within the respective Cure
Periods, the Company’s securities will be subject to delisting. In that event, the Company may appeal such determination to a hearing
panel. The Company currently awaits Nasdaq’s decision and/or comments to the Plan. The Company will also make its best efforts
to regain compliance with all the Listing Requirements prior to the expiration of the Cure Periods.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our securities are delisted by Nasdaq, our securities may be eligible for quotation on an over-the-counter quotation system or on “the
pink sheets” but will lack the benefits and market efficiencies associated with a Nasdaq listing. Upon delisting, our securities
would become subject to the regulations of the SEC relating to the market for penny stocks. The regulations applicable to penny stocks
may severely affect market liquidity in respect of our securities and could limit the ability of shareholders to obtain accurate quotations
as to the market value of and/or dispose of our securities. In such case, there can be no assurance that our securities will be again
be eligible for listing on any recognized exchange.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 30; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
Sponsor and our directors and officers have interests that are different from, or in addition to (and which may conflict with), the interests
of its shareholders, and therefore potential conflicts of interest exist in recommending that shareholders vote in favor of the Business
Combination. Such conflicts of interests include that the Sponsor as well as our directors and officers are expected to lose their entire
investment in the Company if the Business Combination is not completed.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
considering our board’s recommendation to vote in favor of approving any proposals in connection with the Business Combination,
our shareholders should keep in mind that the Sponsor and our directors and officers have interests in such proposals that are different
from, or in addition to (and which may conflict with), those of our shareholders generally.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These
interests include, among other things:</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that immediately following the consummation of the Business Combination, the initial shareholders are expected to hold an aggregate
of 1,993,000 Pubco ordinary shares on an as-converted basis, consisting of (i) 1,725,000 Pubco ordinary shares to be converted from
our ordinary shares held by the initial shareholders, (ii) 234,500 Pubco ordinary shares to be converted from our ordinary shares
underlying the private units held by the initial shareholders; and (iii) 33,500 Pubco ordinary shares to be converted from our ordinary
shares underlying the private rights held by the initial shareholders, which in the aggregate, would represent approximately 6.8%
ownership interest in the Pubco following the consummation of the Business Combination under the no redemption scenario, on an as-converted
basis.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that the Sponsor acquired 234,500 units at a price of $10.00 per private unit through private placement simultaneously with
the closing of our initial public offering on February 23, 2024.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that the initial shareholders paid an aggregate purchase price of $25,000, or approximately $0.01 per share, for 1,725,000 insider
shares prior to our initial public offering, which shall be surrendered to us to exchange for a share certificate representing the
same number of Pubco ordinary shares at the SPAC Merger Effective Time pursuant to the Business Combination Agreement. All of the
insider shares are subject to certain transfer restrictions and could have a significantly higher value at the time of the Business
Combination, which, if unrestricted and freely tradable, would be valued at approximately $20.2 million, based on the most recent
closing price of our ordinary shares of $11.69 per share on October 23, 2025.  </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that if the Business Combination or another business combination is not consummated by February 23, 2027   (if we
extend the Combination Period which may be accomplished only if the Sponsor deposits additional funds into the Trust Account), we
will cease all operations except for the purpose of winding up, redeeming 100% of our outstanding public shares for cash and, subject
to the approval of its remaining shareholders and our board, liquidating and dissolving. In such event, the private units held by
our initial shareholders would expire worthless. If the Business Combination is consummated, each of our outstanding ordinary share
will be converted into one Pubco ordinary share. Given (i) the differential in the purchase price that the Sponsor paid for the insider
shares, as compared to the price of the our ordinary shares, (ii) the differential in the purchase price that the Sponsor paid for
the our private placement units as compared to the price of the public units, and (iii) the substantial number of Pubco ordinary
shares that the Sponsor will receive upon conversion of the initial shares and/or our private placement units, the Sponsor may earn
a positive return on their investment, even if public shareholders have a negative return on their investment.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>
<!-- Field: Page; Sequence: 31; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that the Sponsor has agreed that if we liquidate the Trust Account prior to the consummation of a business combination, it will
be liable to pay debts and obligations to target businesses or vendors or other entities that are owed money by us for services rendered
or contracted for or products sold to us in excess of the net proceeds of our initial public offering not held in the Trust Account,
but only to the extent necessary to ensure that such debts or obligations do not reduce the amounts in the trust account and only
if such parties have not executed a waiver agreement.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that our Sponsor, officers, directors, or their affiliates may, but are not obligated to, loan us funds as may be required (“Working
Capital Loan”) to fund working capital deficiencies or finance transaction costs in connection with an initial business combination.
Up to $300,000 of such Working Capital Loan may be convertible upon consummation of our business combination into private units at
a price of $10.00 per unit.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that the Business Combination Agreement provides for the continued indemnification of our current directors and officers and
the continuation of directors and officers liability insurance covering our current directors and officers.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that Maius, the Sponsor and Pubco will enter into an amendment to the Registration Rights Agreement of our company on or prior
to the Closing which provides for registration rights following consummation of the Business Combination.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that pursuant to the Business Combination Agreement, the Sponsor shall promptly provide non-interest bearing loans to us (the
“Extension Loans”) for the sole purpose of extending the deadline for the consummation of our initial business combination,
which shall immediately be repaid by us to the Sponsor and/or Maius (as the case may be) upon the earlier of the Closing or the expiry
of the deadline for the consummation of our initial business combination.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
fact that in addition to these interests of the Sponsor and our officers, directors and advisors, to the fullest extent permitted
by applicable laws and our memorandum and articles of association, waive certain applications of the doctrine of corporate opportunity
in some circumstances where the application of any such doctrine would conflict with any fiduciary duties or contractual obligations
they may have, and we will renounce any expectancy that any of our directors or officers will offer any such corporate opportunity
of which he or she may become aware to us. We do not believe that the pre-existing fiduciary duties or contractual obligations of
its officers and directors materially impacted its search for an acquisition target. Further, we do not believe that the waiver of
the application of the corporate opportunity doctrine had any impact on its search for a potential business combination target.</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 32; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
personal and financial interests of our directors and officers may have influenced their motivation in identifying and selecting Maius
as a business combination target, completing the Business Combination with Maius and influencing the operation of the business following
the Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no assurance when or if the Business Combination will be completed.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
completion of the Business Combination is subject to the satisfaction or waiver of a number of conditions as set forth in the Business
Combination Agreement, including, among others, (i) receipt of the required approval by our shareholders; (ii) receipt of the required
approval by the shareholders of Maius; (iii) effectiveness of the registration statement (which is to be prepared in connection with
the Business Combination and to call a special meeting of our shareholders requiring us to prepare and file with the SEC) declared by
the SEC; (iv) the approval for Pubco’s initial listing application with Nasdaq; and (v) the absence of any law or governmental
order or legal injunction making illegal the consummation of the Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
assurance can be given that the required consents, orders and approvals will be obtained or that the required conditions to the completion
of the Business Combination will be satisfied. Even if all such consents, orders and approvals are obtained and such conditions are satisfied,
no assurance can be given as to the terms, conditions and timing of such consents, orders and approvals. We cannot provide assurance
that the Business Combination will be completed on the terms or timeline currently contemplated, or at all.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
extraordinary shareholder meeting may take place before all of the required regulatory approvals have been obtained and before all conditions
to such approvals, if any, are known. Notwithstanding the foregoing, if the proposal to conduct the Business Combination and the Transactions
are approved by our shareholders, we would not be required to seek further approval of our shareholders, even if the conditions imposed
in obtaining required regulatory approvals could have an adverse effect on us or Maius.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>The
approval of, or submission of filings with, the China Securities Regulatory Commission (the “CSRC”), may be required in connection
with the Business Combination.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
PRC government has expanded oversight over offerings that are conducted overseas by China-based issuers and foreign investment in China-based
issuers in recent years. On February 17, 2023, the CSRC released the Trial Administrative Measures of Overseas Securities Offering and
Listing by Domestic Companies (the “Trial Measures”), and five supporting guidelines, which came into effect on March 31,
2023. According to the Trial Measures, domestic companies that seek to offer or list securities overseas, both directly and indirectly,
should fulfill certain filing procedures and report relevant information to the CSRC. If the issuer meets both of the following conditions,
an overseas offering and listing will be determined as an indirect overseas offering and listing by a domestic company: (i) any of the
total assets, net assets, revenue or profits of the PRC-incorporated operating entities of the issuer in the most recent accounting year
accounts for more than 50% of the corresponding figure in the issuer’s audited consolidated financial statements for the same period,
and (ii) the issuer’s major operational activities are carried out in the PRC or its main places of business are located in the
PRC, or the senior managers in charge of operation and management of the issuer are mostly PRC citizens or are domiciled in the PRC.
The determination as to whether or not an overseas offering and listing by domestic companies is indirect, shall be made on a substance
over form basis.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to covenants of Maius under the Business Combination Agreement, Maius shall use its commercially reasonable efforts to fulfill the filing
procedure with the CSRC and report relevant information in a timely manner per the requirements of the Trial Measures and the supporting
guidelines. Maius expects to submit the filing application documents according to the Trial Measures and relevant supporting guidelines
within three business days after filing the registration statement in connection with the Transactions with the SEC. It is uncertain
whether Maius will be able to, or how long it will take it to, obtain such approval or complete the filing procedures. Further, the CSRC
could rescind its approval after giving it. Any failure to obtain or delay in obtaining clearance of such approval or completing such
filing procedures for this Business Combination or the Pubco’s proposed listing on Nasdaq, or a rescission of any such approval
obtained by Maius, would subject Maius to regulatory actions or other sanctions by the CSRC or other PRC regulatory authorities for failure
to obtain required governmental authorization. These governmental authorities may impose fines, restrictions and penalties on Maius,
which might make it advisable for Maius to suspend the Business Combination or the Pubco’s proposed listing on Nasdaq. All of these
could have a material adverse effect on our and Maius’ ability to consummate the Business Combination, and could significantly
limit or completely hinder the Pubco’s ability and the ability of any holder of the Pubco’s securities to offer or continue
to offer such securities.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<!-- Field: Page; Sequence: 33; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>There
is no assurance if any PIPE financing as contemplated in the Business Combination can be completed.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to covenants under the Business Combination Agreement, we and Maius have agreed to use commercially reasonable efforts to obtain executed
subscription agreements for an aggregate investment amount of no less than $10,000,000 from third party investors (such investors, collectively,
with any permitted assignees or transferees, the “PIPE Investors”), pursuant to which the PIPE Investors make or commit to
make private equity investments in us, Maius or Pubco to purchase shares of us, Maius or Pubco in connection with a private placement,
and/or enter into backstop or other alternative financing arrangements with potential investors (a “PIPE Investment”). We
may terminate the Business Combination Agreement at any time prior to the Closing if we are not in material breach of any of our obligations
in the Business Combination Agreement while Maius fails to perform such covenants in connection with the PIPE Investment within the time
period specified in the Business Combination Agreement.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
we will continue to work toward obtaining the PIPE Investment on market terms, no subscription agreements have been entered into as of
the date of this Quarterly Report on Form 10-Q. Accordingly, there are substantial uncertainties with respect to the financing amount,
terms and timing of PIPE Investment, as well as the dilutive effect of such PIPE Investment to our non-redeeming shareholders. Furthermore,
there can be no assurances that such PIPE Investment can be secured at all. Lack of PIPE Investment may cause the Business Combination
to become less attractive to some investors, which may make it more difficult for us to complete the Business Combination.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>If
the Business Combination does not constitute an “Exchange” within the meaning of Section 351 of the Code, then the Business
Combination generally will be taxable to U.S. holders.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of us, Maius, Pubco, Merger Sub 1 and Merger Sub 2 intend to take the position that, for U.S. federal income tax purposes, the Transactions
constitute a single exchange transaction under Section 351 of the Internal Revenue Code of 1986, as amended (the “Exchange”).
However, there is a lack of authority supporting the treatment of the Transactions as an Exchange, and accordingly there is significant
uncertainty that the Business Combination would so qualify. Neither us nor Maius intends to request a ruling from the IRS regarding the
U.S. federal income tax treatment of the Business Combination as part of an Exchange, and no assurance can be given that Business Combination
will qualify as part of an Exchange, that the IRS will not challenge this position or that a court will not sustain such a challenge
by the IRS. Further, the Closing is not conditioned upon the receipt of an opinion of counsel that the Transactions will constitute an
Exchange.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the Transactions do not constitute an Exchange, then a U.S. holder generally will recognize gain or loss in an amount equal to the difference
between the fair market value (as of the Closing Date of the Business Combination) of Pubco ordinary shares received in the Business
Combination, over such holder’s aggregate adjusted tax basis in the corresponding public shares surrendered by such holder in the
Business Combination. Even if the Transactions otherwise constitutes an Exchange, U.S. Holders may be required to recognize gain (but
not loss) in the Business Combination under the PFIC rules. The tax consequences of the Business Combination are complex and will depend
on each U.S. holder’s particular circumstances.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
may not have sufficient funds to consummate the Business Combination.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025, we had $0 of cash held outside the Trust Account. If we are required to seek additional capital, we may need to
borrow funds from the Sponsor, directors, officers, their affiliates or other third parties to operate or may be forced to liquidate.
We believe that the funds available to us outside of the Trust Account, together with funds available from loans from Sponsor, its affiliates
or members of our management team will be sufficient to allow us to operate for at least the period ending on February 23, 2027 if
we extend the Combination Period which may be accomplished only if the Sponsor deposits additional funds into the Trust Account. However,
we cannot assure you that its estimate is accurate, and the Sponsor, directors, officers and their affiliates are under no obligation
to advance funds to us in such circumstances.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
<!-- Field: Page; Sequence: 34; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Our
management concluded that there is substantial doubt about its ability to continue as a “going concern.”</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 30, 2025, we had $1,598,106 of cash and investments held in the Trust Account to be used for a business combination or to
repurchase or redeem our ordinary shares in connection therewith. If we are unable to raise additional funds to alleviate liquidity needs
and complete a business combination by February 23, 2027   if we extend the Combination Period which may be accomplished only
if the Sponsor deposits additional funds into the Trust Account, we will cease all operations except for the purpose of liquidating.
The liquidity condition and date for mandatory liquidation and subsequent dissolution raise substantial doubt about our ability to continue
as a going concern.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>We
depend on a variety of U.S. and multi-national financial institutions to provide us with banking services. The default or failure of
one or more of the financial institutions that we rely on may adversely affect our business and financial condition.</i></b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain the majority of our cash and cash equivalents in accounts with major U.S. and multi-national financial institutions, and our
deposits at certain of these institutions exceed insured limits. Market conditions can impact the viability of these institutions. In
the event of the failure of any of the financial institutions where we maintain our cash and cash equivalents, there can be no assurance
that we would be able to access uninsured funds in a timely manner or at all. Any inability to access or delay in accessing these funds
could adversely affect our liquidity, business and financial condition.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-009"></span>ITEM
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Unregistered
Sales of Equity Securities</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
August 2022, an aggregate of 1,725,000 insider shares were issued to our initial shareholders, for an aggregate purchase price of $25,000,
or approximately $0.01 per share. The insider shares held by our initial shareholders included an aggregate of up to 225,000 shares subject
to forfeiture by our sponsor to the extent that the underwriters’ over-allotment option was not exercised in full or in part, so
that our initial shareholders would collectively own 20.0% of our issued and outstanding shares after our initial public offering (excluding
the sale of the private units and the representative shares and assuming our initial shareholders did not purchase units in our initial
public offering). On February 21, 2024, the underwriters exercised their over-allotment option in full.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Simultaneously
with the closing of our initial public offering on February 23, 2024, we consummated the private placement with DT Cloud Capital Corp.,
our sponsor, of 234,500 units at a price of $10.00 per private unit. This issuance was made pursuant to Section 4(a)(2) of the Securities
Act, as the transaction did not involve a public offering. No underwriting discounts or commissions were paid with respect to the private
placement.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On May 21, 2025, the Company and Maius entered into Voting Agreements with the Non-Redeeming Shareholders. Pursuant to the Voting Agreements,
in the event a shareholder redeems the Redemption Shares and foregoes the exercise of their redemption rights in connection with the Non-redeemed
Shares, vote in favor of the approval of the Extension Fee Reduction, for any proposal to adjourn or postpone the applicable general meeting
to a later date proposed by the Company for purposes of obtaining the approval of the Extension Fee Reduction and against any action,
proposal, transaction or agreement that would reasonably be expected to result in a breach in any respect of any covenant, representation
or warranty or any other obligation or agreement of the Investors in this Agreement. The Company agrees to issue to the Non-Redeeming
Shareholders the Additional SPAC Rights for each Non-redeemed Share for no additional consideration. An aggregate of 781,879 Additional
Rights were issued to the Non-Redeeming Shareholders on July 25, 2025. This issuance was made pursuant to Section 4(a)(2) of the Securities
Act. No registration under the Securities Act of the Additional Rights is required for the Company’s issuance of the Additional
Rights to the Non-Redeeming Shareholders solely in the manner contemplated by the Voting Agreements.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use
of Proceeds</i></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
February 23, 2024, we consummated the initial public offering of 6,900,000 units, which includes the exercise in full by the underwriters
of their over-allotment option to purchase up to an additional 900,000 units on February 21, 2024. The units were sold at an offering
price of $10.00 per unit, generating gross proceeds of $69,000,000. Simultaneously with the closing of our initial public offering on
February 23, 2024, we consummated the private placement with DT Cloud Capital Corp., our sponsor, of 234,500 units at a price of $10.00
per private unit, generating total gross proceeds of $2,345,000.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of February 23, 2024, a total of $69,345,000 of the net proceeds from our initial public offering and the private placement were deposited
in a trust account established for the benefit of our public stockholders at Morgan Stanley, with Continental Stock Transfer & Trust
Company, acting as trustee.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Brookline
Capital Markets, a division of Arcadia Securities, LLC served as the representative of the underwriters of our initial public offering.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
securities sold in our initial public offering were registered under the Securities Act pursuant to a registration statement on Form
S-1 (File No. 333-267184) (the “Registration Statement”). The SEC declared the Registration Statement effective on February
14, 2024.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
has been no material change in the planned use of proceeds from our initial public offering and the private placement as described in
our final prospectus dated February 20, 2024.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"></p>
<!-- Field: Page; Sequence: 35; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-010"></span>ITEM
3. DEFAULTS UPON SENIOR SECURITIES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-011"></span>ITEM
4. MINE SAFETY DISCLOSURES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Not
applicable.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-012"></span>ITEM
5. OTHER INFORMATION</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">None.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-013"></span>ITEM
6. EXHIBITS</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on Form 10-Q.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
No.</b></span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.1*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 0.1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-1.htm">Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">31.2*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex31-2.htm">Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.1**</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-1.htm">Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif">
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">32.2**</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ex32-2.htm">Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Instance Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Schema Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline
XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover
Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
herewith</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">**</span></td>
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furnished
herewith</span></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<!-- Field: Page; Sequence: 36; Value: 3 -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
<div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt"> </p></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="Y-014"></span>SIGNATURES</b></span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned, thereunto duly authorized.</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date:
November 26, 2025</span></td>
<td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>DT
Cloud Acquisition Corporation</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
<td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
Guojian Chen</i></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guojian
Chen</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
<td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief
Executive Officer, Chief Financial Officer and Director</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Principal
Executive Officer and Principal Financial and Accounting Officer)</i></span></p></td></tr>
</table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span> </p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<!-- Field: Page; Sequence: 37; Options: Last -->
<div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
<!-- Field: /Page -->
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- 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 -->
</body>
</html>